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ABSTRACT
Periodontitis is an infection-driven inflammatory disease affecting tooth-supporting 
tissues, i.e., the periodontium. Whole saliva, an easily obtained specimen, is
attractive to be used in diagnosis of periodontitis with/without clinical examination. 
The aim of this PhD work was to investigate the presence and levels of various
salivary biomarkers of infection, inflammation, and tissue degradation.
This PhD study consisted of salivary specimens from two different study
populations: a subsample of the national Health 2000 survey (n = 220) and the
Parogene cohort study (n = 445/455). Phospholipid transfer protein (PLTP) activity
and salivary concentrations of a chemokine (interleukin (IL)-8), cytokines (IL-1β, -
17A, -23, lymphotoxin-˜ (LTA)), myeloperoxidase (MPO), and bone remodeling-
related biomarkers (RANK-ligand, osteoprotegerin, osteocalcin, and osteopontin)
were examined. The pre-existing data included clinical and radiographic oral
examinations, Cumulative Risk Score (CRS), subgingival bacterial detection, saliva
and serum lipopolysaccharide (LPS) activity, saliva and serum antibodies against
selected bacteria, glycemic status, risk haplotype of human major histocompatibility
complex (MHC) class III, and LTA gene polymorphisms. 
Salivary PLTP activity was lowest in individuals with advanced tooth loss. LPS
activity in saliva was associated with high CRS, while IL-1°, IL-17A, and IL-23 
concentrations varied depending on clinical periodontal status. There were
associations between salivary IL-8 concentrations and bleeding on probing, probing 
pocket depth, and the number of teeth, and between MPO concentrations and
alveolar bone loss. Bone remodeling-related biomarkers in saliva were either
affected by glycemic status or detected at very low levels. CRS associated strongly
with subgingival microbial profile and high levels of antibodies against five
periodontal pathogens, and additionally, with elevated values of bleeding on 
probing, probing pocket depth, alveolar bone loss, and number of teeth. MPO was
the only biomarker associating with the MHC class III risk haplotype of
periodontitis. LTA concentration in saliva associated with LTA gene variants.
The results of this PhD study suggest that IL-1° , IL-17A, MPO, and CRS are
potential salivary biomarkers to be used in large-scale studies where the aim is to
indicate the presence or progression/remission of periodontitis. 
KEYWORDS: Periodontitis, saliva, biomarkers, host response, diagnostics
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TIIVISTELMÄ
Parodontiitti on hampaan kiinnityskudoksiin vaikuttava infektiolähtöinen tulehduk-
sellinen sairaus. Helposti kerättävä kokosylki on yksi mielenkiintoisimmista
näytteistä käytettäväksi parodontiitin diagnostiikan tukena. Tämän työn tavoitteena
oli tutkia useiden infektiota, inflammaatiota ja kudostuhoa kuvaavien merkki-
aineiden esiintymistä ja pitoisuutta syljessä.
Väitöskirjatyön sylkinäytteet ovat peräisin kahdesta eri tutkimusväestöstä: otos
(n = 220) Terveys 2000 -tutkimuksesta ja Parogene-kohorttitutkimuksen aineisto (n
= 445/455). Syljestä tutkittiin fosfolipidiä siirtävän proteiinin (PLTP) aktiivisuutta
sekä kemokiinin (interleukiini (IL)-8), neljän sytokiinin (IL-1β, -17A, -23, 
lymfotoksiini-˜ (LTA)), myeloperoksidaasin (MPO) ja neljän luumetaboliaan 
liittyvän merkkiaineen (RANK-ligandi, osteoprotegeriini, osteokalsiini, osteo-
pontiini) pitoisuutta. Käytettävissä oli suun kliininen ja röntgenologinen tutkimus-
data sekä tiedot yhdistelmämerkkiaineeseen (CRS) perustuvasta parodontaali-
statuksesta, subgingivaalisista bakteereista, syljen ja seerumin lipopolysakkaridin
(LPS) aktiivisuudesta, syljen ja seerumin tietyistä bakteerivasta-aineista, sokeri-
tasapainosta, ihmisen MHC-kompleksin luokan III riskihaplotyypistä sekä LTA-
geenin polymorfismeista. 
Syljen PLTP-aktiivisuus oli matalin tutkituilla, joilla oli eniten menetettyjä
hampaita. LPS-aktiivisuus ja korkea CRS olivat yhteydessä toisiinsa, kun taas
kliininen parodontaalistatus liittyi syljen IL-1β-, IL-17A- ja IL-23-pitoisuuksiin.
Ienverenvuodolla, taskusyvyyksillä ja hampaiden lukumäärällä oli yhteys syljen IL-
8-pitoisuuteen ja MPO-pitoisuudella lisäksi horisontaaliseen alveoliluukatoon.
Verensokeritasapaino vaikutti osaan luumetaboliaan liittyvistä merkkiaineista, kun
taas osa löytyi hyvin matalina pitoisuuksina. CRS yhdistyi merkittävästi
subgingivaaliseen bakteeriprofiiliin ja kohonneisiin parodontopatogeenien vasta-
ainepitoisuuksiin, sekä lisääntyneeseen ienverenvuotoon, syviin ientaskuihin,
alveoliluukatoon ja hampaiden menetyksiin. Syljen MPO-pitoisuus yhdistyi MHC-
kompleksin luokan III riskihaplotyyppiin ja LTA LTA geenivariantteihin.
Tämän väitöskirjatutkimuksen tulosten perusteella voidaan esittää, että IL-1β, 
IL-17A, MPO ja CRS ovat potentiaalisia syljen biologisia merkkiaineita
käytettäväksi laajoissa väestötutkimuksissa parodontiitin toteamiseksi.
AVAINSANAT: Parodontiitti, sylki, biomarkkerit, isännän vaste, diagnostiikka
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BOP Bleeding on probing
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ELISA Enzyme-linked immunosorbent assay
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HbA1c Serum glycated hemoglobin 
hBDs Human β-defensins
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PCR Polymerase chain reaction
PGE2 Prostaglandin E2 
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PLTP Phospholipid transfer protein
PMN Polymorphonuclear leukocyte, neutrophil
POC Point-of-care
PPD Probing pocket depth
PRR Pattern recognition receptor
qPCR Quantitative real-time PCR
RANKL Receptor activator for nuclear factor κB ligand
ROS Reactive oxygen species
SNP Single nucleotide polymorphism
SPSS˛ Statistical Package for Social Sciences
TGF-β Transforming growth factor-β
TIMP Tissue inhibitor of matrix metalloproteinase
Th T helper cell
TLR Toll-like receptor
TNF Tumor necrosis factor
VDR Vitamin D receptor
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1 Introduction
Periodontitis is a multifaceted biofilm-induced inflammatory disease, which affects
tooth-supporting structures, and eventually leads to destruction of periodontal tissue. 
Periodontitis is traditionally diagnosed with clinical and radiographical
examinations. However, in large-scale population studies, this approach may not be
feasible because the diagnosis requires trained dental professionals and takes a 
considerable amount of time. An easy-to-use specimen like saliva for recognizing
the disease could be a promising tool for this challenge. Although salivary
diagnostics cannot give a site-specific diagnosis of periodontitis, they can provide
information on overall periodontal health status and susceptibility factors. In 
addition, saliva is non-invasively and inexpensively obtained without the need for
special equipment or experienced personnel (Miller et al., 2010). 
Mainly Gram-negative periodontal pathogens located at the subgingival sites and 
their biologically active surface structures contribute to the host immune response.
Inflammatory immune response plays a key role in pathogenesis and progression of
periodontitis (Darveau, 2010). Accumulating knowledge on infection-induced 
inflammatory responses, especially on cytokine functional networks, has improved 
our understanding on periodontal pathogenesis and brought potential bacteria- and 
host-originated biomarkers for salivary diagnostics in periodontology (Preshaw and 
Taylor, 2011). Among studied biomarker candidates, however, only few are well-
established to be suitable for clinical use. Before highly effective diagnostics can be
launched to the daily practice, there is a need to confirm a suitable marker, or most
probably, a combination of markers (He et al., 2018). Many practical problems (e.g.,
very low salivary concentrations) and patient-related problems (e.g., the impact of
systemic conditions on salivary biomarker levels) need to be solved to utilize
periodontal salivary diagnostics (Taylor, 2014). 
This study series, evaluating salivary and serum levels of selected biomarkers,
was performed to provide further information on suitability of these biomarkers for
salivary diagnostics.
11 
 
     
  
   
   
  
  
    
  
   
 
 
  
 
         
  
        
   
    
    
      
   
  
 
   
    
  
     
     
    
  
          
2 Review of the Literature
2.1 Structures and functions of the periodontium
Tooth-supporting structures consist of the gingiva, periodontal ligament, root
cementum, and alveolar bone. The function of the periodontium is to attach the tooth
to the jaw, support teeth against masticatory friction and forces, and to act as a barrier
against microbes. In a clinically healthy situation, there are no signs of clinical
inflammation (i.e., gingival redness, swelling, bleeding, or exudate), and the
periodontium sustains its consistency and structure. 
The gingiva is the part of the oral mucosa that conceals the alveolar bone and
encircles teeth. The gingival sulcus is the shallow crevice around the tooth between
the epithelium lining of free gingiva and the surface of the tooth. Clinically, a probing 
pocket depth (PPD) of gingival sulcus less than 4 mm is considered as one of the
signs of periodontal health (Chapple et al., 2018).
The gingival epithelium can be divided into three different anatomical sections
in morphologic and functional point of view; the oral outer epithelium, sulcular
epithelium, and junctional epithelium. The structure of the junctional epithelium is
highly porous and provides transit passage for neutrophils (also known as
polymorphonuclear leukocytes (PMNs)) throughout the epithelium into the gingival
sulcus. The junctional epithelium also secretes chemokines and cytokines, and thus
has a regulator role in innate immune defense, and it acts as a barrier against constant
microbial challenge (Bosshardt and Lang, 2005). Under the epithelium, the gingiva
has underlying connective tissue, lamina propria, blood and lymphatic components,
and nerves. 
The periodontal ligament is composed of complex vascular and highly cellular
connective tissue. The most important elements of periodontal ligament are the 
collagenous fiber bundles inserting to the cementum and alveolar bone (Hassel,
1993). The cementum is a calcified, avascular tissue that forms the outer covering to
the root and provides an attaching surface to the periodontal ligament.
The alveolar bone, a tooth-dependent structure, is formed when tooth erupts, and
it disappears gradually after the tooth is lost. Bone has a constant physiological
remodeling process, and several systemic and local factors affect this process. It is
12
 
 
 
  
  
   
    
     
    
   
   
    
  
  
   
 
  
       
 
      
   
  
  
 
   
 
   
           
    
 
   
 
       
    
  
    
  
    
Review of the Literature
also notable that the remodeling process has similarities with many aspects of
inflammation and repair processes (Sodek and McKee, 2000).
2.2 Periodontal pathogenesis
In a healthy situation, commensal bacteria in dental biofilms maintain a low-level
innate immune response, which is essential to the homeostasis of host tissues. An
altered microbial composition of subgingival biofilm is an etiological factor of
periodontal disease (Darveau, 2010). The host response mounts when the
periodontium attempts to eliminate periodontal pathogens. In susceptible
individuals, this results in a dysregulated production of inflammatory mediators,
such as cytokines, chemokines, prostanoids, and enzymes. In periodontitis, this
response fails to clear periodontal pathogens but leads to periodontal tissue
destruction (Ebersole et al., 2013). 
2.2.1 Resident microbiota and pathogenic biofilms
The mouth is one of the most heavily bacteria-colonized parts of the human body.
The relationship between the host and his/her microbiome is dynamic. The balance
of this relationship is crucial for oral health. Microbial communities in the mouth
have multiple functions including metabolic, physiological, and immunological
actions. Many host-related factors, such as smoking and stress, affect the microbiota.
In order to properly understand the microbiota, the host and microbes need to be
taken as one unit, holobiont (Kilian et al., 2016). 
Oral microbes tend to aggregate with each other and adhere to specific surfaces
of the oral cavity. They form structurally and functionally organized bacterial
communities, biofilms, where they can survive and multiply (Sanz et al., 2017).
Periodontal health-associated commensals are important in maintaining the balance
of the microbiota. In periodontally healthy individuals, subgingival biofilms seem to
be quite stable (Kumar et al., 2006), while shifting of their microbial composition,
dysbiosis, associates with periodontitis (Sanz et al., 2017). Qualitative and 
quantitative alterations with enrichment of certain potential pathogens within
subgingival biofilms expose to the initiation of periodontal disease. Nutrients arising
from tissue destruction and the anaerobic environment of deepening periodontal
pocket together form favorable conditions for inflammophilic periodontal pathogens
and pathobionts to grow (Hajishengallis, 2014; Jiao et al., 2014; Herrero et al., 2018). 
Traditionally, the color-coded complexes have provided a framework for
describing subgingival bacterial ecosystems (Socransky et al., 1998; Socransky and
Haffajee, 2005). The model clusters the species highly associated with each other
and differentiates the clusters with color codes. The green, purple, and yellow
13 
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complexes represent early colonizers. The more pathogenic orange complex and,
eventually, the most pathogenic red complex, including Porphyromonas gingivalis, 
Tannerella forsythia, and Treponema denticola, are facilitated by early colonizers 
(Socransky et al., 1998). The orange complex with a moderate association with
periodontitis contains Fusobacterium nucleatum, Parvimonas micra, Prevotella
intermedia, and Prevotella nigrescens, and also Campylobacter rectus is frequently 
found in periodontitis individuals (Socransky et al., 1998; Könönen et al., 2007;
Teles et al., 2010). Besides the red complex species, Aggregatibacter
actinomycetemcomitans has been stated to be one of the major periodontal pathogens
(Könönen and Müller, 2014). 
Host response against pathogens shows individual variability, diminishing the
value of their recognition but highlighting the impact of dysbiosis (Lloyd-Price et
al., 2016). Red and orange complex bacteria are still considered to have an important
role in dysbiotic microbial communities. The development of sequencing techniques
and knowledge of microbial communities have emerged new periodontal pathogens,
such as Porphyromonas endodontalis (Hajishengallis and Lamont, 2012; Pérez-
Chaparro et al., 2014) and increased awareness of different roles of known species
like F. nucleatum and P. gingivalis. Traditionally F. nucleatum is seen as an
important bridging organism (Kolenbrander et al., 2010), but it also enhances oxygen
tolerance within biofilms and induces an environmental change in biofilms through 
hypoxia (Gürsoy et al., 2010b; Mendes et al., 2018). 
The virulence of periodontal pathogens is based on their ability to invade
periodontal tissues and produce molecules that activate host immune response.
Besides bacterial antigens, potential virulence factors include endotoxins like
lipopolysaccharide (LPS) of Gram-negative bacteria, exotoxins (e.g. the leukotoxin
of A. actinomycetemcomitans), and proteolytic enzymes, (e.g., gingipains) (Taylor,
2010). Exposure to bacterial antigens triggers the production of antibodies by the
host and binding of these antibodies to bacteria is a hallmark of adaptive immunity.
Since the mouth is heavily colonized with bacteria, detectable amounts of antibodies
against oral bacteria can also be measured from healthy individuals. Local
production of antibodies against periodontal bacteria results in their higher levels in
gingival crevicular fluid (GCF) than in serum (Engström et al., 1993; Ebersole et al.,
2013).
2.2.2 Inflammatory and immune pathways
An appropriate immune response is important in maintaining periodontal health. 
Primary defense mechanisms of the host include the epithelium barrier (cell-to-cell 
junctions, high renewal capability, and antimicrobial peptide production),
commensal microbiota (competition with pathogens and maintaining the protective
14
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host response), and saliva and GCF flow (protective enzymes and antibodies)
(Schroeder and Listgarten, 1997; Taylor, 2010). 
The first stage of host response at the cellular and molecular levels is innate 
immunity. Cells of the periodontium, such as epithelial cells, fibroblasts, neutrophils,
natural killer (NK) cells, and dendritic cells, sense microbial presence through an
array of pattern recognition receptors (PRRs) on their surfaces (Mahanonda and
Pichyangkul, 2007). Activation of PRRs, e.g., Toll-like receptors (TLRs), leads to
the recruitment of specific cells (neutrophils, monocytes), formation of antigen-
presenting cells (macrophages, dendritic cells), and activating molecular
mechanisms (Garlet et al., 2006; Trombone et al., 2009). Due to the activation of
innate immunity, cells of the periodontium initiate to secrete proinflammatory
cytokines (e.g., interleukin (IL)-1, -6, -8, and tumor necrosis factor (TNF)-α, growth
factors (e.g., epidermal growth factor), proteases (matrix metalloproteinase (MMP)
-2, -7, -9, -13), and natural antimicrobial peptides (β-defensins (hBDs), cathelicidin
LL-37) (Bosshardt and Lang, 2005). Neutrophils are stimulated by these
inflammatory mediators, and their amount is increased on sulcus area (Tonetti et al.,
1998). At an inflamed site, neutrophils identify and eliminate bacteria either by 
phagocytosis or directly through the release of oxidative (myeloperoxidase (MPO))
or enzymatic (serine protease) molecules. Neutrophils use oxidative or non-oxidative
mechanisms to kill bacteria within phagosome (Odeberg and Olsson, 1976;
Klebanoff, 2005) and MPO is involved in activation of neutrophil elastase
proteolytic activity during the process called NETosis (Metzler et al., 2014). Also,
monocytes destroy bacteria by phagocytosis (Stuart and Ezekowitz, 2005). Innate
immune response is amplified and synchronized by the complement pathway
(Damgaard et al., 2015). 
If innate immunity is not successful and bacterial challenge is prolonged, an
antigen-specific adaptive immune response emerges. Dendritic cells and 
macrophages perform an important link between innate and adaptive immunity 
acting as antigen-presenting cells (Théry and Amigorena, 2001; Barker et al., 2002).
Adaptive immunity can be divided into two lines: T-lymphocytes mainly associate 
with cell-mediated and B-lymphocytes with antibody-mediated immunity. Adaptive
immune response is highly specific and sustained. 
Depending on antigen-presenting interactions and cytokine load, naïve T-cells 
can differentiate into T helper 1 (Th1) cells, Th2 cells, Th17 cells, Th9 cells,
regulatory T-cells (Treg), or unconventional T-cells (γ˝T cells) (Dutzan et al., 2016).
The expression of cell surface molecules (in the gingiva most commonly CD4 or
CD8) alters the functions of T-cells. CD4-positive T-cells are Th1 cells that secrete 
interferon-γ (INF-γ) and promote cell-mediated immunity by activating
macrophages and NK cells. CD8-positive Th2 cells secrete IL-4, IL-5, and IL-13, 
and regulate antibody-mediated immunity and mast cell activity (Mosmann and
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Coffman, 1989). Th17 cells secrete IL-17 and IL-22, and they are important in
immunity reactions against extracellular bacteria. IL-17 has a number of
proinflammatory activities together with IL-1β and TNF-α (Korn et al., 2009).
Recent evidence has enhanced the role of Th17 cells in the periodontium as
regulators of T-cell response and bone resorption (Campbell et al., 2016). Treg cells
help to dampen down immune responses and maintain tolerance against self-
antigens, secrete transforming growth factor-β (TGF-β) and IL-10, and have a role
in regulating other T-cell subsets (Josefowicz and Rudensky, 2009). 
Various developmental stages of B-cells, leading to antibody-producing plasma
cells, are also regulated by several cytokines and other factors (Goodnow et al.,
2010). Five different classes of antibodies have been identified, including
immunoglobulin A (IgA), IgG, IgM, IgD, and IgE (Ebersole et al., 2013). In the field
of periodontal research, IgA/IgG are frequently determined. IgG antibodies with
long half-life represent the overall exposure to bacteria and are extremely stable in
plasma (Papapanou et al., 2004; Lakio et al., 2009). Short half-time IgA antibodies
represent recent or continuous exposure to pathogens (Boillot et al., 2016). Plasma
cells also contribute to periodontal tissue destruction by producing cytokines, like
TNF-α, IL-6, IL-10, and TGF-β. Yet, it is not well understood how different
cytokines act in a network in pathogenesis of periodontitis (Preshaw and Taylor,
2011).
2.2.3 Periodontal tissue destruction
Periodontal tissue destruction occurs when phagocyte- and lymphocyte-dominated
host responses drive a katabolic activity of periodontal tissues via overexpressed 
inflammatory cytokines and enzymes (Garlet et al., 2006; Trombone et al., 2009).
Due to the presence of cytokines in inflamed tissue, various inflammatory mediators 
(e.g., prostaglandins) are upregulated resulting in multiple and highly complex
feedback loops (Preshaw and Taylor, 2011). After their critical level is reached,
degradative mediators (e.g., receptor activator for nuclear factor κB ligand (RANKL)
and MMP-8) are produced, leading to the destruction of connective tissue and 
alveolar bone. At the same time, production of endogenous inhibitors (e.g.,
osteoprotegerin (OPG) and tissue inhibitors of matrix metalloproteinases (TIMPs))
of the degradative mediators are inhibited. Connective tissue destruction is involved
in MMP-8 and MMP-9 predominance caused by neutrophil emigration to inflamed
site (Miller et al., 2010). Reactive oxygen species (ROS), like MPO, enhance
imbalance between MMPs and TIMPs (Hernández et al., 2011). The osteoclastic
effect of RANKL in alveolar bone occurs via its ability to activate osteoclastogenesis
by binding to RANK. OPG, instead, neutralizes RANKL and prevents its action.
(Ebersole et al., 2013). This manner is not unique for inflammation but part of normal
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homeostasis. Namely, the distribution between degradative mediators and their
inhibitors ratio has been implicated to pathogenesis of periodontitis (Sorsa et al.,
2006; Saint-Pastou Terrier and Gasque, 2017). Prolonged imbalance leads to 
periodontal tissue destruction, which is seen as a clinical manifestation of
periodontitis. 
Figure 1. Pathogenesis of periodontal disease. hBDs = human β-defensins, LL-37 = cathelicidin 
LL-37, PRRs = pattern recognition receptors, ROS = reactive oxygen species.
2.2.4 Risk factors
Several individual-based risk factors have roles in the initiation, progression, and 
severity of periodontal disease. Smoking, male gender (mainly for behavioral
reasons), diabetes, and obesity are well established risk factors by changing
individuals’ susceptibility or resistance but cannot cause the disease without the 
emergence of periodontal pathogens. Osteoporosis, stress, and genetic factors are
17 
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considered potential risk factors, but more evidence is needed before a clear
consensus of their roles can be reached (Genco and Borgnakke, 2013). Although the
influence of smoking can be changed via smoking cessation as part of the periodontal
treatment, some risk factors, like genetics, are rigid. Modifying the risk factor(s) is
usually beneficial for the management of periodontal disease. The current literature
suggests bi-directional associations between periodontitis and other chronic
inflammatory diseases like diabetes, cardiovascular disease, and rheumatoid arthritis
(Pizzo et al., 2010). It has also been estimated that there are common genetic variants,
which associate both with periodontitis and with cardiovascular disease (Aarabi et
al., 2017). 
Smoking is associated with the oral microbial shifting, changes in host response,
and impaired wound healing (Johnson and Hill, 2004; Kumar et al., 2011). In 2012,
the estimated global age-standardized prevalence of daily tobacco smoking for men 
was 31.1% and for women 6.2% in the population older than 15 years (Ng et al.,
2014). According to the Finnish Health 2000 survey, the percentage of smokers
among the males was 29% and among the females 18% (Aromaa and Koskinen, 
2004). A meta-analysis (Genco and Borgnakke, 2013) estimated that smokers are at
2.8 times higher risk of developing periodontitis compared to non-smokers, and the
risk seems to be dose-dependent. 
Diabetes and periodontal disease have a bi-directional relationship. It is assumed
that an elevated production of proinflammatory mediators, such as IL-1β, IL-6, and
TNF-α, leads to more severe periodontitis and poor diabetes metabolic control. Also 
bone metabolism is involved in this bi-directional association; bone is acting as an
endocrine organ regulating glucose metabolism and, at the same time,
hyperglycemia may modulate the RANKL/OPG ratio in periodontal tissues (Ferron
et al., 2010; Taylor et al., 2013). Altered balance in bone metabolism, for example 
reduced bone formation in periodontitis-associated alveolar bone loss, is called
uncoupling and is a common finding also in diabetes (Graves et al., 2011). A global
comparative diabetes prevalence in 20–79-year-old individuals is estimated to be
9.3% and to grow during following decades (Saeedi et al., 2019). According to the
Health 2000 survey, 0.5% of Finns aged 30 or older suffered from type 1 diabetes,
and in addition, 4% of males and 3% of females had type 2 diabetes (Aromaa and
Koskinen, 2004). 
There is evidence that obesity and metabolic syndrome associate with
periodontal disease. The exact mechanisms still remain open but possible
explanations include the changes in the oral microbiome and chronic systemic
inflammatory response (Genco and Borgnakke, 2013). The prevalence of obesity has
increased during the past decades. In 2008, a global mean age-standardized body 
mass index (BMI) was 23.8 kg/m² for men and 24.1 kg/m² for women, and the global
age-standardized obesity (BMI ≥30 kg/m2) prevalence was 9.8% for men and 13.8%
18
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for women (Finucane et al., 2011). According to the Health 2000 survey, in the
population of 30 years or older, 21.2% of males and 23.5% of females were obese
(Aromaa and Koskinen, 2004). 
Genes regulate the functions of the human body but act differently under
different environmental factors (Barros et al., 2018). In chronic diseases like
periodontitis, multiple genes play a limited role in progression of the disease, being
rather disease-modifying genes than risk variants. Some genes and their variants
(polymorphisms) influence the host response to the bacterial load, thus playing part
in periodontal disease (Laine et al., 2012). At a genome-wide significance level, few
susceptibility gene variants have associated with periodontitis, and the heritability
seems to increase with severity of periodontitis (Munz et al., 2019; Nibali et al., 
2019; Morelli et al., 2020). A review of Laine et al. (2012) summarized that
polymorphisms in genes IL1, IL6, IL10, vitamin D receptor (VDR), CD14, TLR14,
and MMP1 may have an association with periodontitis susceptibility, while a recent
meta-analysis (Weng et al., 2016) connected polymorphisms in genes MMP3, 
MMP8, and MMP9 to periodontitis susceptibility. A certain haplotype within the
LTA gene seems to be involved in the susceptibility towards periodontitis (Zupin et
al., 2019), and polymorphisms in genes MMP3, CD28, and VDR to initial 
periodontitis (Heikkinen et al., 2016). Yet, it is not possible to evaluate the impact
of multiple genes and polymorphisms on the host response under different
environmental conditions (Schaefer, 2018). 
Since the genes regulate the host response, it is argued that genetics may
influence subgingival colonization in periodontitis (Zhang et al., 2020). Plausible 
mechanisms relate to changes in genes that are associated with pathways of bacteria
recognition or excessive inflammatory environment caused by altered genes, and
which favors the growth of specific bacteria. The genes involved in infection, innate
and adaptive immune response, and chronic inflammation are carried, for example,
in the human major histocompatibility complex (MHC) region located in the
chromosome 6. Several inflammation-related proteins, e.g., heat shock proteins, 
TNF, and lymphotoxins, are in the MHC class III region (Yung Yu et al., 2000).
Variations in the MHC region may be important in susceptibility for periodontitis
(Palikhe et al., 2008; Folwaczny et al., 2011; Kallio et al., 2014). Locus 6p21.3 in
the MHC region has been estimated to have an association with “high periodontal
pathogen colonization” traits in genome-wide association studies (Divaris et al.,
2012). In a study of Kallio et al. (2014), BAT1-NFKBIL1-LTA risk haplotype was
proven to be a significant contributor to the risk of having periodontitis. Bleeding on 
probing, deepened periodontal pockets of ≥6 mm, and severe periodontitis had the
strongest association with this risk haplotype. 
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2.3 Periodontal disease
Periodontitis is an infection-induced inflammatory disease affecting tooth-
supporting structures. Periodontitis affects not only the gingival epithelium and 
connective tissue under it, but also periodontal ligament and, in particular, alveolar
bone. When chronic gingival inflammatory process leads to the activation of
osteoclastogenenesis, irreversible changes in alveolar bone occur.  
2.3.1 Clinical parameters & traditional diagnostics 
The major clinical characteristics of periodontitis are the pocket formation and loss
of attachment. Traditionally clinical parameters form a base for a diagnosis of
periodontitis and are used in daily practice. Bleeding on probing (BOP) indicates
gingival inflammation and active tissue destruction, while PPD ≥4 mm indicates a
history of periodontal tissue destruction or gingival swelling. Other clinical
parameters, clinical attachment level (CAL) and alveolar bone loss (ABL), indicate
a history of periodontal tissue destruction, especially alveolar bone destruction. CAL
is defined clinically and ABL on radiographs. However, measurements based on
marginal radiographic bone loss are not specific enough (Tonetti et al., 2018). 
The latest consensus report for the classification for periodontal diseases was
published in 2018 (Papapanou et al., 2018). According to this new classification,
staging and grading are used to describe the severity of periodontitis and risk for its 
progression. Certain risk factors, smoking and glycemic status, are used as grade
modifiers. A diagnosis of periodontitis is defined primarily when interdental CAL is
detectable at ≥2 non-adjacent teeth, or buccal or oral CAL ≥3 mm with pocketing >3
mm is detectable at ≥2 teeth. The new classification also helps to avoid paradox
involved in recession of disease severity observed after tooth loss. 
The latest classification is the first one defining periodontal health (Chapple et
al., 2018). The important change in this new classification is moving from PPD to
CAL as the primary clinical parameter of tissue destruction. Although PPD is not the
primary clinical parameter, it is still an important part of clinical examination,
especially, before the new classification is adopted properly in daily practice. 
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Figure 2. Periodontal anatomy in health and disease. Left side represents a healthy state. Right
side represents periodontitis. ABL = alveolar bone loss, CEJ = cemento-enamel
junction, PPD = probing pocket depth.
2.3.2 Epidemiology
There is an increasing global burden of periodontitis (Jin et al., 2016). The
occurrence of periodontal attachment loss increases already relatively early in
adulthood. The progression accelerates with age. Especially smokers have a risk for
progression of attachment loss (Thomson et al., 2013). It has been estimated that
mild or moderate periodontitis affects the majority of adults. The global age-
standardized burden of severe periodontitis (PPD ≥6 mm or CAL >6 mm) in years
1990–2010 was evaluated to be 11.2% (Kassebaum et al., 2014). On a national level
in Finland, according to the Health 2000 survey, 67% of the population of 30 years
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or older had at least one periodontal pocket of ≥4 mm (72% of males and 57% of
females), and 21% had at least one periodontal pocket of ≥6 mm (26% of males and 
16% of females), showing that periodontitis is more common in men than women,
and its prevalence is increasing with age (Suominen-Taipale et al., 2008).
2.4 Body fluids for estimating oral health
2.4.1 Saliva as a body fluid 
In the context of salivary diagnostics, whole saliva is used to describe combined fluids
of the mouth. Whole saliva is a mixture of pure glandular saliva, serum-derived GCF, 
desquamated oral epithelial cells, other cellular components, micro-organisms and 
their by-products, and exogenous material (Nieuw Amerongen et al., 2007). 
Antimicrobial innate defense proteins and peptides of saliva (e.g., lactoferrin, 
lactoperoxidase, and defensins) protect all oral tissues against microbial attacks (Gorr,
2009). The most important function of saliva is to provide protection against microbes, 
physical stress, and chemical stress. Besides the protective properties, saliva acts as 
nutrient source for oral microbes (Marsh et al., 2016). Physical and chemical functions
are related to fluidity, including lubrication or clearance, or specific components, such 
as buffering capacity (Dawes, 2008). There is a large variation in the composition of
saliva among individuals and different parts of the oral cavity. Local (e.g., radiation
therapy) and systemic (e.g., medications, acquired immune deficiency syndrome,
Parkinson’s disease, Sjögren’s syndrome) factors affect the quality of the salivary
functions (Mese and Matsuo, 2007; Grundmann et al., 2009).
2.4.2 Salivary diagnostics in general
Saliva is an advantageous diagnostic specimen. In addition to its local components
(e.g., proteins synthesized by acinar cells of salivary glands, bacteria, mucosal cells),
saliva contains most of the same molecules that can be found in the systemic
circulation, as the serum components of saliva are derived from the local vasculature
that originates from the carotid arteries, and thus it may offer even more information
than serum (Hofman, 2001; Miller et al., 2010). There is emerging evidence on
effects of non-oral diseases (systemic diseases, genetic disorders, immunodeficiency
states, and metabolic disorders) on salivary microbial composition; specific
microbial consortia may relate to range of systemic conditions widening the
diagnostic value of saliva (Acharya et al., 2017). Salivary levels of various medicines
reflect the available (unbound to proteins) concentrations in plasma (Tabak, 2007;
Lee et al., 2009). Obtaining salivary samples is an inexpensive, non-invasive, 
patient-friendly, and safe procedure. Handling, storage, and shipping do not require
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special arrangements unlike anti-coagulants in blood transfer.  Self-collection is also
possible (Raju et al., 2019).
Saliva has been shown to be suitable diagnostic medium for many purposes. For
example, the detection of several viral infections is possible from a saliva sample
(Corstjens et al., 2016). Point-of-care (POC) saliva diagnostics complementary to
electrocardiography may provide a rapid screening method for cardiac events for acute
myocardial infarction patients (Floriano, 2009). Adenosine deaminase in saliva is an 
additional diagnostic and prognostic marker for squamous cell carcinoma of tongue
(Rai et al., 2011). Especially steroid hormones found in saliva reflect the concentration 
of unbound steroids in serum. Hormone analysis of saliva has many applications, for 
example, for doping testing and fertility medicine (Gröschl, 2008). Alcohol and
narcotic substances (e.g., amphetamines, cannabinoids, cocaine and opiates) can also 
be detected from saliva (Bendtsen et al., 1999; Bosker and Huestis, 2009).
In dentistry, saliva tests have been utilized as an aid when assessing individuals´ 
caries susceptibility by evaluating the presence and amount of lactobacilli and
mutans streptococci (Alaluusua et al., 1990), acid production by oral bacteria
(Sánchez-Pérez et al., 2009), and oligosaccharides of glycoproteins (Denny et al.,
2007)
2.4.3 Gingival crevicular fluid (GCF)
Compared to saliva, GCF is a site-specific oral fluid. GCF is a serum-based fluid
originating from the blood vessels of the gingival plexus. It contains components
derived from serum, gingival tissues, and subgingival microorganisms (Barros et al.,
2016). It is a physiological fluid (transudate) in health and an inflammatory exudate
during disease. Like saliva, GCF is considered a potential specimen to detect
periodontitis, and biomarker concentrations in GCF are generally higher than those
in saliva. The composition of GCF changes during progression of periodontitis and
due to the high accuracy even subclinical changes can potentially be detected (Barros
et al., 2016). Volumes of GCF samples are relatively small, usually less than 2 µl, 
and various sampling methods have been reported (He et al., 2018). Collection of
GCF is more laborious and has a risk for contamination while on saliva this risk is
minimal (Wu et al., 2018). Due to the sensitive collection protocols, the use of GCF
is restricted for oral health professionals. 
2.4.4 Serum & serum antibodies
In large-scale population studies, clinical periodontal examinations are not always
possible to carry out due to practical limitations. If salivary samples have not been
included in the study protocol, serum may be used as a specimen to detect individuals
23 
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with periodontitis.  Many potential salivary biomarkers of periodontitis (e.g., MMP-
8, MMP-9, and MPO) can also be found in serum. Systemic conditions, however,
may affect serum biomarker levels; for example, statin users have lower MMP-8, 
MMP-9, and MPO levels in serum than in saliva (Lahdentausta et al., 2018). 
It has been shown that LPS can penetrate into periodontal tissues and end up to
blood circulation, increasing the risk of systemic problems in periodontitis subjects
(Bascones-Martínez et al., 2009). A study performed in mice demonstrated that oral
administration of P. gingivalis led to increased endotoxin levels in serum, affecting
the gut microbiome (Sato et al., (2017). Previous reports indicate that serum LPS
correlates with periodontal status and serum LPS activity decreases after periodontal
treatment (Pussinen et al., 2004; Paju et al., 2006; Masi et al. 2018). 
On one hand, elevated antibody (IgA/IgG) levels against periodontal pathogens
in serum of periodontitis patients indicate that they could be used as biomarkers of
periodontitis in large-scale population studies (Ebersole et al., 1987; Papapanou et
al., 2000; Dye et al., 2009; Pussinen et al., 2011; Kudo et al., 2012; Buhlin et al., 
2015; Gadekar et al., 2018). On the other hand, serum antibody levels are mostly
related to the carriage of periodontal pathogens, while periodontitis has only a
modest effect (Pussinen et al., 2011). Combining salivary and systemic biomarkers
in detection of periodontitis has been proposed to overcome this limitation, and the
sensitivity and specificity of this approach was demonstrated (Liljestrand et al.,
2014; 2018). Nevertheless, both the composition of the oral microbiota and serum
antibody response are prone to the presence and severity of endocrine disorders
(Akcalı et al., 2014). Thus, the validity and reliability of serum markers for detecting 
periodontitis under systemic conditions require further studies.
2.5 Potential salivary biomarkers of periodontitis
This section is concentrating on potential salivary biomarkers associated with
periodontal disease. Besides IL-1β, TNF-α, IL-6, and RANKL, the markers 
highlighted by The 7th European Workshop on Periodontology (Kinane et. al., 2011),
the section contains markers dealt in Studies I-IV (LPS, PLTP, IL-8, IL-17, IL-23, 
LTA, MPO, OPG, osteopontin, and osteocalcin), and the MMP-TIMP axis.
2.5.1 Agents related to periodontal infection
2.5.1.1 Bacteria & immunoglobulins
Saliva has proven to be a suitable specimen to detect periodontitis-associated
bacteria, especially A. actinomycetemcomitans, P. gingivalis, P. intermedia, T. 
forsythia, C. rectus, and T. denticola, in large-scale studies utilizing polymerase 
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chain reaction (PCR)-based assays (Könönen et al., 2007; Paju et al., 2009). In 
individuals with periodontitis, there is a correlation between salivary and subgingival
levels of specific periodontal pathogens (Haririan et al., 2014), also before and after
periodontal treatment (Belstrøm et al., 2018). Salivary microbiota might be a 
promising tool for evaluating periodontal conditions, and the detection of multiple
bacterial species in saliva is superior to that of a single pathogen (Paju et al., 2009;
Kageyama et al., 2017; Cieplik et al., 2018).
The odds for pathogen presence can also be evaluated by using serum or saliva
IgA/IgG against periodontal pathogens instead of direct detection of those pathogens
(Kinane et al., 1999; Plombas et al., 2002; Pussinen et al., 2011; Ebersole et al.,
2013). IgA/IgG binding to bacteria in saliva has been studied for A.
actinomycetemcomitans, P. gingivalis, T. denticola, P. intermedia, and F. nucleatum
(Sandholm et al., 1987; Hägewald et al., 2000; 2002; 2003; Plombas et al., 2002). In
individuals with periodontitis, elevated salivary levels of IgA have been reported
against A. actinomycetemcomitans (Plombas et al., 2002; Gadekar et al., 2018) and
P. gingivalis (Plombas et al., 2002), and elevated salivary IgG levels against A. 
actinomycetemcomitans (Gadekar et al., 2018), as well as against A. 
actinomycetemcomitans leukotoxin (Engström et al., 1999).
2.5.1.2 Lipopolysaccharide
Lipopolysaccharide is a surface structure on the outer membrane of Gram-negative 
bacteria. It is one of the main inducers of the host immune response via TLR
activation in periodontal disease. LPS triggers the proinflammatory cytokine
production initially via the myeloid differentiation primary response protein 88
(MyD88)-dependent pathway, which further activates the mitogen-activated protein
kinases (MAPKs) pathways and IκB kinase (IKK) complex (Molteni et al., 2016).
In the case of late response, LPS triggers the MyD88-independent pathway to 
activate the IFN regulatory factor 3 (IRF3) transcription factor, which promotes the
type I interferon production. Dendritic cells have a central role in the recognition of
LPS and initiation of infection-induced adaptive immune cascade (Kikuchi et al., 
2004). Moreover, LPS seems to have a cytokine upregulation effect on several cell
types, and it enhances the production of macrophages as an innate immune response. 
One study showed that IL-23 expression in periodontal ligament cells was induced
by P. endodontalis LPS (Ma et al., 2017). Another study demonstrated that the
production of IL-17 and IL-23 was significantly increased in P. gingivalis LPS-
treated human periodontal ligament cells (Park et al., 2012). In periodontology
probably the most important LPS is that of P. gingivalis, a key pathogen of
periodontitis (Hajishengallis, 2014). Many studies related to LPS and host response,
however, are performed with Escherichia coli LPS. Since LPS differs between
25 
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different Gram-negative species, also their effects differ from each other (Taylor, 
2010; Strachan et al., 2019).  Data on the applicability of salivary LPS levels for
detection of periodontitis are very limited. Previous studies suggest differences in 
salivary levels of LPS between individuals with and without periodontal disease
when investigating on structural alterations in lipid-A-derived 3-OH fatty acid
profiles or using a bioassay for Toll-like receptors 2 and 4 stimulants (Buduneli et
al., 2011; Lappin et al., 2011). Moreover, in saliva samples the lipid A chemical 
structure of LPS differs in periodontitis patients versus healthy individuals indicating
increased activity and inflammatory potential of LPS in periodontitis (Mcilwaine et
al., 2020). Thus, the regulation of LPS chemical structure seems to have an important
role determining whether host bacteria relationship is symbiotic or pathogenic. LPS 
activity in saliva has been shown to correlate to the number of remaining teeth with 
a linear trend, but no relation to clinical periodontal parameters has been found
(Hyvärinen et al., 2012; Liljestrand et al., 2017). 
2.5.1.3 Phospholipid transfer protein
Plasma PLTP plays an important role in plasma lipid metabolism, and it is part of
the protein family involved in binding and neutralization of bacterial LPS. PLTP has
an ability to promote LPS disaggregation and LPS binding to high density
lipoprotein (HDL), resulting in the elimination of LPS from the body (Gautier and
Lacrost, 2011; Yu et al., 2016). Since PLTP protects against inflammation triggered
by LPS, it can be considered a potential biomarker of Gram-negative bacterial load
in periodontal salivary diagnostics. No data exist on the presence or activity of PLTP
in saliva. The PLTP activity has been shown to be related to periodontitis in studies,
where plasma values were measured before and after periodontal treatment or full
mouth tooth extraction (Pussinen et al., 2004; Vuletic et al., 2008).
2.5.2 Markers of inflammation
2.5.2.1 Interleukins
Probably the most studied salivary cytokine to date is IL-1. It includes two isoforms,
IL-1α and IL-1β, of which IL-1β is a significant stimulant of bone destruction, being
involved in periodontitis (Masada et al., 1990). IL-1β is produced by multiple cells,
mainly by fibroblasts, keratinocytes, osteoblasts, macrophages, dendritic cells,
monocytes, and leukocytes (Cochran, 2008; Liu et al., 2010; Groeger and Myele,
2015). It is an essential proinflammatory cytokine and, in addition, it induces the
synthesis and expression of several other inflammatory mediators. The effects of IL-
1β are caused mainly via its ability to enhance the antigen-mediated stimulation of
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T-cells (Ben-Sasson et al., 2009). IL-1β also induces various vascular changes during
the inflammatory process and regulates neutrophil emigration from the circulation 
to the periodontium, often in synergy with TNF-α and prostaglandin E2 (PGE2) 
(Taylor, 2014). Furthermore, IL-1β is a potent inducer of bone resorption and 
connective tissue degradation via its ability to induce MMPs (Birkedal-Hansen, 
1993). High concentrations of IL-1β in saliva have been associated with periodontal
tissue destruction (Miller et al., 2006; Ng et al., 2007; Tobón-Arroyave et al., 2008;
Gürsoy et al., 2009; Fine et al., 2009; Salminen et al., 2014). IL-1β has a very high
potential as a salivary biomarker, since its salivary concentrations are not affected
by systemic conditions like diabetes or smoking (Jaedicke et al., 2016). 
Interleukin-6 is a central proinflammatory cytokine involved in homeostasis and
inflammatory pathways. It is produced at early phases of immune responses
(Kishimoto, 2005) by a wide range of immune cells, including T- and B-cells, 
macrophages, and dendritic cells, as well as non-immune cells, including 
keratinocytes, endothelial cells, and fibroblasts. The production of IL-6 is activated
by a number of cytokines, e.g., IL-1β and TNF-α (Van Snick, 1990). IL-6 has an
important role in acute inflammation, and it promotes bone resorption (Preshaw and
Taylor, 2011). It stimulates MMP secretion of fibroblasts and enhances the
inflammatory response to bacterial load in many ways. It also amplifies the
inflammatory process and plays a role in T-cell differentiation and the regulation of
T-cell balance (Preshaw and Taylor, 2011). The diagnostic performance of IL-6 as a 
single biomarker is at most acceptable, but its combinatory use, especially with
MMP-8, may provide improved diagnostic accuracy (Kc et al., 2020). 
Interleukin-8 is a chemotactic cytokine inducing the chemotaxis in neutrophils 
and their migration to the infection site (Groeger and Meyle, 2015). Oral bacteria
induce IL-8 production in gingival epithelial cells through TLR-9 (Kim et al., 2012).
Also IL-1β may stimulate the production of IL-8 in oral keratinocytes (Tonetti, 1997)
and several other immune and non-immune cells (Commins et al., 2010). Although
IL-8 is connected to inflammation, many cross-sectional studies have failed to show
an association between salivary concentrations of IL-8 and periodontitis or tissue
destruction (Scannapieco et al., 2007; Teles et al., 2009; Rathnyake et al., 2013),
however, also opposite reports exist (Kim et al., 2016; Özcan et al., 2016; Kaczyński
et al., 2019). Significantly reduced salivary levels have been observed in 
periodontitis individuals after mechanical periodontal therapy (Sexton et al., 2011;
Özcan et al., 2016). A recent meta-analysis by Finoti et al. (2017) reported
conflicting evidences regarding IL-8 levels in saliva. 
The IL-23/IL-17 axis is one important pathway in an infection-induced 
inflammatory process. IL-23 is produced by monocytes, macrophages, and dendritic
cells in response to bacterial load (Preshaw and Taylor, 2011). It promotes the
differentiation of naive CD4+ T-cells into Th17 cells (Iwakura and Ishigame, 2006;
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Mills, 2008; Korn et al., 2009). Activated Th17 cells produce IL-17 family cytokines
(to date consisting of six members, IL-17A – IL-17F), of which IL-17A is dealt in
this work. IL-17A is a proinflammatory cytokine that induces inflammation and bone
resorption, stimulating the release of chemokines and expression of matrix
metalloproteinases (Beklen et al., 2007; Gu et al., 2013). Various effects of IL-17A
are the result of synergy with other cytokines like IL-1β, TNF-α, and INF-γ (Kramer 
and Gaffen, 2007; Korn et al., 2009; Onishi and Gaffen, 2010; Cheng et al., 2014).
There is increasing evidence on the role of IL-17 in immune-mediated inflammatory
diseases (e.g., psoriasis, rheumatoid arthritis) (Bunte and Beikler, 2019). 
To date, only limited data exist on the role of Th17 cells and IL-17A in the
periodontal pathogenesis, and only three studies have reported on the presence of
salivary IL-17A. On one hand, IL-17A levels have shown to be lower in generalized
periodontitis individuals than in controls (Ozçaka et al., 2011a), and on the other
hand, higher levels have been reported in periodontitis individuals than in controls
(Awang et al., 2014; Kaczyński et al., 2019). One study found an association
between the mean pocket depth and salivary IL-17A concentrations (Gürsoy et al.,
2015).
In the majority of recent studies, without further subgrouping, elevated IL-17 
concentrations were detected in individuals with periodontitis (Marques et al., 2016;
Yang et al., 2016; Batool et al., 2018), but there is also opposing report (Prakasam
and Srinivasan, 2014). However, one study has reported low detection frequencies
of IL-17 in saliva samples, weakening its potential to be used in salivary diagnostics
(Isaza-Guzmán et al., 2015).  
No previous data on salivary IL-23 concentrations exist. There is limited amount
of conflicting evidence on IL-23 concentrations in GCF samples. One study showed
that IL-23 concentrations were proportional to the amount of periodontal tissue
damage (Himani et al., 2014), while the other study found relatively high IL-23 
concentrations in healthy individuals and lower concentrations in chronic
periodontitis individuals without statistical significance (Sadeghi et al., 2018).
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Figure 3. Schematic picture of inflammatory pathway of periodontitis.
2.5.2.2 Other cytokines
Tumor necrosis factor-α is an essential regulator of immune and inflammatory
responses. It is mainly produced by macrophages and T-lymphocytes. Also
neutrophils, B-cells, fibroblasts, osteoclasts, and endothelial cells can produce TNF-
α. Its proinflammatory effects result from the effects on endothelial cells and their
interactions with leukocytes (neutrophil degranulation). TNF-α is also related to
vasodilatation and increased vascular permeability via induction of cyclooxygenase
(COX)-2 expression in endothelial cells (Pershaw and Taylor, 2011). The effects of
TNF-α in the pathogenesis of periodontitis occur via its ability to induce connective
tissue destruction and bone resorption (Stashenko et al., 1987). Due to low salivary 
concentrations of TNF-α, its usability in salivary diagnostics has been questioned 
(Jaedicke et al., 2016).
LTA (formerly known as TNF-β) is a proinflammatory cytokine involved in the
recruitment of inflammatory cells and alveolar bone loss (Assuma et al., 1998).
Lymphotoxins are mostly produced by lymphocytes and NK cells (von Boehmer,
1997). Serum LTA concentrations have shown to correlate with deepened 
periodontal pockets and the number of teeth (Kallio et al., 2014). There are limited 
data on the link between LTA salivary levels and periodontitis so far. The only
available study on salivary LTA concentration demonstrated an inverse relation to
the percentage of periodontal pockets (Shyu et al., 2015). 
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2.5.3 Markers of periodontal tissue destruction
2.5.3.1 Myeloperoxidase
The main role of MPO is to generate hypochlorous acid to kill bacteria. MPO has
also an oxidative function to activate proMMPs, especially MMP-8 and -9, to their
active forms and inactive TIMPs. (Saari et al., 1990; Spallarossa et al. 2008;
Hernández et al., 2011). MPO is mainly released from neutrophils, and its production
is induced by host inflammatory mediators like TNF-α, LTA, and IL-1β (Richter,
1990; Saari et al., 1990; Buchmann et al., 2002; Bosshardt and Lang, 2005). In GCF
samples, MPO is a highly discriminatory biomarker for site-specific diagnosis of
periodontitis (Leppilahti et al., 2014). Elevated levels of salivary MPO have been
related to periodontitis (Sakamoto et al., 2008; Meschiari et al., 2013; Nizam et al.,
2014; Rathnayake et al., 2015; Lahdentausta et al., 2018), however diagnostic power
of salivary MPO was found to be low (sensitivity 64% and specificity 62%;
Lahdentausta et al., 2018).
2.5.3.2 Matrix metalloproteinases and their inhibitors
The MMP superfamily consists of over 25 proteolytic enzymes, which can be
classified into collagenases, gelatins, stromelysins, membrane-type MMPs, and 
other MMPs. The effects of MMPs are related to their ability to degrade extracellular
matrix components. They have several functions involving the regulation of immune
responses and tissue destruction. In periodontal diseases, degradation of soft tissues 
and organic matrix of the bone are mainly regulated by MMPs (Sorsa et al., 2004;
2006). MMPs are produced by a variety of immune and non-immune cells, including
neutrophils, macrophages, monocytes, plasma cells, keratinocytes, fibroblasts, 
periodontal ligament cells, osteoblasts, and osteoclasts. Several host-related
inflammatory cytokines, such as IL-1β and TNF-α, regulate the secretion and
activation of MMPs (Sorsa et al., 2006). MMP activation or activity is inhibited by
TIMPs and catalytic competence controlled by proenzymes (Sorsa et al., 2004). 
Collagenase-type MMP-8 (also known as collagenase-2) and gelatinase-type MMP-
9 predominate in the pathogenesis of periodontitis. MMP-8 is able to break type I
and III collagens, while MMP-9 has ability to degrade type IV and V collagens 
(Miller et al., 2010). It is well established that elevated salivary MMP-8 and MMP-
9 concentrations are associated with periodontitis (Miller et al., 2010; Taylor, 2014), 
but smoking limits the diagnostic value of MMP-8 by decreasing its salivary levels
(Sorsa et al., 2016). Fragmented salivary MMP-8 is a potential but not yet enough 
studied form of MMP-8 to be used as salivary biomarker (Gürsoy et al., 2018a)
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The TIMP family consists of four different proteins (TIMP-1 to TIMP-4). 
Besides the inhibition of MMPs, TIMPs have several other functions like cell growth
promotion, matrix binding, and induction of apoptosis (Brew et al., 2000). Of those, 
TIMP-1 is most common in salivary diagnostics within periodontology. TIMP-1 is 
secreted by several non-immune cells (keratinocytes, endothelial cells and
fibroblasts) and migratory immune cells (monocytes and macrophages) (Miller et
al., 2010). Imbalance in the MMP/TIMP ratio has been implicated to the
pathogenesis of periodontitis (Sorsa et al., 2006). Many studies indicate reduced
levels of TIMP-1 in saliva of periodontitis individuals or a negative correlation 
between salivary levels and clinical signs of oral inflammation, but there is some
diversity in results. A high MMP-8/TIMP-1 ratio measured from saliva seems to
associate with periodontitis or worsened clinical signs of oral inflammation
(Hayakawa et al., 1994; Gürsoy et al., 2010a; Isaza-Guzmán et al., 2011; Meschiari
et al., 2013; Nizam et al., 2014; Rathnyake et al., 2015). 
2.5.3.3 Bone metabolism markers
RANKL and OPG are important bone metabolism-related biomarkers involved in
homeostasis and pathologic resorption of alveolar bone. The functions of RANKL
in homeostasis are related to bone renewal, optimal T-cell activation, and dendritic
cell survival. In the pathogenesis of periodontitis, several proinflammatory
cytokines, such as IL-1β and TNF-α, have the ability to activate osteoclastogenesis
via upregulating the production of RANKL in activated T-cells and osteoclasts, but
also in many other cell types. An increased expression of RANKL stimulates
preosteoclasts to mature in active osteoclasts (Preshaw and Taylor, 2011; Ebersole
et al., 2013; Saint-Pastou Terrier and Gasque, 2017). Besides bone formation,
osteoblasts have an important role in maintaining bone homeostasis through the
secretion of OPG, which inhibits the action of RANKL by blocking its binding to its
receptor (Saint-Pastou Terrier and Gasque, 2017). Proinflammatory cytokines may 
inhibit the osteoblast formation (Graves et al., 2011). In the periodontium, OPG is
mainly produced by resident connective tissue cells (Belibasakis and Bostanci,
2012). An increased RANKL/OPG ratio is associated with increased
osteoclastogenesis and alveolar bone breakdown (Belibasakis and Bostanci, 2012;
Saint-Pastou Terrier and Gasque, 2017). 
Elevated levels of RANKL in saliva have been associated with periodontitis 
(Tobón-Arroyave et al., 2012; Tabari et al., 2013; Ochanji et al., 2017; Borges et al.,
2019). However, these levels seem to be low, and in some cases even below the 
detection limit (Frodge et al., 2008). Concerning OPG, equivocal results have been
found; while some studies indicated decreased salivary levels in periodontitis
individuals (Ramseier et al., 2009; Tabon-Arroyave et al., 2012; Ochanji et al., 
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2017), other studies presented increased levels in saliva (Miller et al., 2006; Costa et
al., 2010; Al-Sabbagh et al., 2012), and one study did not find any relation to
periodontitis (Tabari et al., 2013). A recent meta-analysis by Di Lenardo et al. (2019)
failed to show statistically significant associations between salivary OPG levels and
periodontitis. The RANKL/OPG ratio, on the other hand, is significantly higher in
individuals with periodontitis than in those without (Tobón-Arroyave et al., 2012;
Tabari et al., 2013). Moreover, a strong correlation has been found between
periodontal disease severity and the RANKL/OPG ratio in saliva (Ochanji et al.,
2017). Nevertheless, the RANKL-OPG ratio in GCF samples seems to stay
unchanged after non-surgical periodontal treatment (Bostanci et al., 2011), 
indicating that clinical healing response is not reflected to site-specific levels of these
markers. Possible mechanisms behind this observation could be related to 
continuous RANKL and OPG expressions during periodontal wound healing and 
remodeling (Baharuddin et al., 2015) or the presence of residual pockets with active 
disease progression (Borges et al., 2019). 
Osteocalcin and osteopontin are non-collagenous calcium-binding proteins of
the bone. They form an important component of bone matrix and take part in bone
remodeling. Osteocalcin is synthesized by osteoblasts (Booth et al., 2013). During
inflammation, proinflammatory cytokines can decrease osteocalcin production in 
osteoblasts (Graves et al., 2011). Ostepontin is produced by osteoblasts and
osteoclasts, while increased levels of osteopontin in inflamed tissues are mainly
produced by macrophages and activated T-cells (Denhardt and Noda, 1998).
Circulating osteocalcin has been associated with new osteoblasts and bone
formation, whereas fragmented osteocalcin has been associated with bone loss
(Seibel, 2005). In studies using GCF, the greatest promise for detection of
periodontitis appears to be on detecting fragmented osteocalcin (Taba et al., 2005).
Osteocalcin levels in GCF have shown to be reduced in individuals with periodontitis
(Becerik et al., 2011). There is variation in the results of studies using saliva; an 
association of elevated osteocalcin concentrations with periodontitis has been found
in some studies (Ozçaka et al., 2011b; Miricescu et al., 2014; Betsy et al., 2019), but
also negative results have been reported (Bullon et al., 2005). No data exist on 
salivary osteopontin levels in relation to periodontitis. In one study, it was shown
that, before and after treatment with melatonin, changes in the pocket depth
correlated with changes in salivary levels of osteopontin (Cutando et al., 2013). In
another study, periodontal treatment did not significantly affect the salivary levels of
osteocalcin and osteopontin (Beiler et al., 2020). A limited number of GCF-based
results are available and they indicate that osteopontin levels are increased in
periodontitis individuals (Kido et al., 2001; Sharma and Pradeep, 2006).
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Figure 4. Schematic picture of alveolar bone destruction.
2.5.4 Combinatory use of salivary biomarkers
During the past decades, several biomarkers, such as bacteria and bacterial products,
and host-derived agents linked to inflammation and tissue destruction, have been
examined and associated with different stages of periodontal conditions (Miller et
al., 2010; He et al. 2018). Since the pathogenesis of periodontitis is complicated, it
is challenging to define a gold standard to salivary tests in periodontology. Both 
saliva- and GCF-based results indicate that the usability of a single biomarker varies 
(Arias-Bujanda et al., 2019; Kc et al., 2020), and that a combinatory use of salivary 
biomarkers improves diagnostic accuracy. Methods of saliva collection, storage, and
analysis vary among studies and restrict assignment of fixed thresholds for salivary
biomarker concentrations. Using a combination of salivary biomarkers associated
with different stages of periodontal inflammation gives more comprehensive 
information than a single marker alone (Gürsoy et al., 2011; 2018b). 
It has been hypothesized that the nature of chronic periodontitis is a dynamic
fluctuating condition (Kinney, 2011). The three main phases of periodontal
inflammation are bacterial burden, inflammation, and tissue destruction, following
each other in cycles as visualized in Figure 5. Due to the fluctuation, a single marker
associating with only one phase cannot recognize individuals in other phases of the
disease. This weakens the diagnostic value of a single biomarker and encourages a 
combinatory use of salivary biomarkers. One approach for a combination marker is
33 
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Cumulative Risk Score (CRS) developed by Gürsoy et al. (2011). CRS combines the
levels of three selected salivary biomarkers, P. gingivalis, IL-1β, and MMP-8. These
biomarkers represent those three main phases of periodontal inflammation and are
individually well-established biomarkers of periodontitis. CRS uses an adaptive
study design to distribute the study population into tertiles taking the concentration
ranges of selected salivary biomarkers into account. After calculating multiplication
of independent biomarker tertiles, individuals are divided into three groups: low, 
middle, and high risk for having periodontitis. It has been confirmed that CRS
associates with periodontitis more strongly than any of the three selected biomarkers
alone (Gürsoy et al., 2018b; Salminen et al., 2014).
Figure 5. Fluctuating nature of periodontitis. Published in Gürsoy et al., 2011. Reprinted with
permission of Hindawi journals.
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3 Aims
The hypothesis of the thesis is that selected salivary biomarkers have an association
with periodontitis, periodontal parameters, genetic risk of periodontitis, microbial
biomarkers or glycemic status.
The overall aim of the study series (I–IV) was to investigate salivary
concentrations of various biomarkers with an intention to find most potential ones
for detection of periodontitis. The specific aims were:
– to evaluate the diagnostic potential of microbial burden-related LPS and
PLTP activities (I, III, IV), and inflammation-related IL-1β, -8, -17A,  
-23, LTA (I, IV), tissue destruction-related MPO (IV), and bone
remodeling-related RANKL, OPG, osteocalcin, and osteopontin (II)
concentrations in saliva
– to determine whether glycemic status affects the relationship between
bone remodeling biomarkers and periodontal status (II)
– to profile microbiological and immunological signatures of the
Cumulative Risk Score (CRS) via examining its association with saliva
and serum antibodies against periodontal pathogens, LPS, and subgingival
periodontal pathogens (III)
– to examine whether CRS or salivary levels of PLTP activity, LTA, IL-8, 
and MPO relate to risk haplotype of MHC class III region BAT1-
NFKBIL1-LTA (IV).
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4 Materials and Methods
4.1 Study populations & specimens
4.1.1 Health 2000 survey
Studies I and II are based on the subpopulation of 220 individuals, originating from
the southern Finland district of Finnish Health 2000 survey, which was carried out
by National Public Health Institute (KTL) (currently National Institute for Health
and Welfare (THL)). The details of the survey are reported elsewhere (Suominen-
Taipale et al., 2008). The individuals were included on the basis of having a salivary
sample, recorded periodontal status, at least 20 teeth, and no systemic diseases. Of
the 220 individuals, 113 were males and 107 females. Their age varied between 40 
to 60 years (mean age 50 years). All individuals of the Health 2000 survey gave a 
written informed consent and the study protocols were approved by the Ethical
Committee for Epidemiology and Public Health of the Hospital District of Helsinki
and Uusimaa, Finland. 
Clinical oral examinations were carried out by trained dentists and radiographic
examinations from digital panoramic radiographs by a specialist of oral radiology.
At oral examinations, the deepest measurement for each tooth was recorded as
follows: no periodontal pocket, PPD 4-5.5 mm, and PPD ≥6 mm. ABL was measured
from the mesial and distal surfaces of each tooth and on the furcation areas in mm.
The groups describing periodontal status were performed on the basis of PPD ≥4 mm
as follows: 79 controls with no PPD ≥4 mm, 36 subjects having two teeth with PPD
≥4 mm (initial localized periodontitis, LP1), 29 subjects having seven teeth with PPD
≥4 mm (localized periodontitis, LP2), and 76 subjects having at least 14 teeth with
PPD ≥4 mm (generalized periodontitis, GP). The radiographic ABL data were used
when applying statistical tests with bone remodeling-related biomarkers.
Paraffin-stimulated whole saliva samples were collected on the same
appointment before the intraoral examination. Saliva samples were stored at -70°C
until used. Then, the selected samples were thawed and centrifuged at 9 300 g for 5 
minutes at room temperature. Supernatants were used for salivary biomarker
measurements. Details of salivary collection procedures can be found elsewhere
(Heistaro, 2008). 
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Materials and Methods
Venous blood samples were collected to obtain serum samples. They were
allowed to clot for 20 minutes and centrifuged at 1 600–1 800 g for 10 minutes before
transferring to the storage tubes. Serum samples were stored at -70°C until used.
Detailed methods described elsewhere (Heistaro, 2008)
4.1.2 Parogene study
Studies III and IV are based on the subpopulation of the Corogene study, a 
prospective cohort of consecutive individuals who underwent coronary angiography 
in Helsinki University Central Hospital (Finland). In this Parogene study, the oral
health of the participants was examined. The details of the Corogene and Parogene
studies are reported earlier (Buhlin et al., 2011, Vaara et al., 2012). All participants
of the Parogene study gave a written informed consent, and the study protocols were
approved by the Helsinki University Central Hospital ethics committee, Finland. 
In the current PhD work, individuals with saliva determinations (n = 445, 87.6%
of the Parogene cohort, Study III) or with a salivary sample and genetic information
(n = 455, 89.6% of the Parogene cohort, Study IV) were included.
Clinical oral examinations were performed by two calibrated periodontists and
the radiographic examination from digital panoramic radiographs was carried out by
a specialist of oral radiology. For clinical periodontal examinations, PPD and BOP 
were recorded. Extent of ABL was evaluated radiologically. The Parogene study 
population included 30 edentulous individuals. Details of oral examination are found 
elsewhere (Buhlin et el., 2011; Kallio et al., 2014). In Study III, the periodontal
classification was used only when characterizing the study population and it was
based on ABL and PPD as reported earlier by Salminen et al. (2014). In Study IV, 
instead of defining different periodontitis groups, the periodontal parameters BOP,
PPD, and ABL were used in statistical analyses.
Paraffin-stimulated whole saliva samples were collected on the same
appointment before intraoral examination. Saliva samples were stored at -70°C until
used. Then, the selected samples were thawed and centrifuged at 9 300 g for 5 
minutes at room temperature. Pellets were used for bacteria measurements and
supernatants for all other salivary biomarker measurements. Details of saliva 
collection are reported earlier (Buhlin et al., 2011). 
Venous blood samples were collected to obtain serum samples. The blood-based
samples were handled according to the laboratory standards of the Helsinki
University Central Hospital and serum samples were stored at -80°C until used
(Vaara et al., 2012).
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4.2 Collected data
4.2.1 Antibodies against periodontal pathogens
Serum levels of IgA and IgG against whole cell antigens of A. 
actinomycetemcomitans, P. gingivalis, P. endodontalis, P. intermedia, and T. 
forsythia were measured by an enzyme-linked immunosorbent assay (ELISA)
(Pussinen et al., 2002; 2011), and details of these analyses are published earlier
(Hyvärinen et al., 2012; Liljestrand et al., 2018). Salivary levels of IgA/IgG against
the same whole cell antigens were measured by a chemiluminescence immunoassay
and details of these analyses are described elsewhere (Akhi et al., 2019).
4.2.2 Cumulative Risk Score (CRS)
The idea of CRS is to identify the individuals with periodontal disease. The
calculation of CRS for each individual in a study population is made by dividing the
salivary concentrations of P. gingivalis (from saliva supernatant), and IL-1β and 
MMP-8 (from saliva pellets) into tertiles, which are converted to a numerical value
of 1, 2, or 3, and then multiplicating the values of each biomarker to a cumulative
sub-score (Gürsoy et al., 2011). The final CRS groups formed are as follows: CRS
I, indicating the lowest risk (the cumulative sub-scores of 1, 2, and 3); CRS II,
indicating the middle risk (the cumulative sub-scores of 4, 6, 8, and 9); and CRS III,
indicating the highest risk (the cumulative sub-scores of 12, 18, and 27) of having
periodontitis (Gürsoy et al., 2011). The CRS groups used in the current PhD work
have been performed and described in detail previously (Salminen et al., 2014).
4.2.3 Genetic risk profiles and LTA polymorphisms
Parogene study participants were genotyped for single nucleotide polymorphisms
(SNPs). The genetic risk haplotype of MHC class III region BAT1-NFKBIL1-LTA 
was identified via statistical analyses. Detailed information on the genotyping
protocol and constructing the risk haplotype is given elsewhere (Kallio et al., 2014).
In Study IV, the individuals were further divided as having the risk haplotype in 
either chromosome or being without the risk haplotype.
The information of LTA SNPs in >0.7 linkage disequilibrium (LD) with the
rs1041981 was selected for further statistical analyses. These polymorphisms were
rs2857708, rs2009658, and rs2844482 (Study IV).
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Materials and Methods
4.3 Laboratory analyses
This section, which starts with a table listing the biomarkers and related information,
describes the methods used in this PhD work. 
Table 1. Summary of the biomarkers used this study. All the laboratory analyses were done
blindly.
BIOMARKER STUDY SPECIMEN METHOD LOD
Subgingival bacteria III Pooled subgingival
plaque
Checkerboard DNA-
DNA hybridization
104 cells
LPS activity I and III Saliva LAL assay N/A
LPS activity III Serum LAL assay N/A
PLTP activity IV Saliva Lipoprotein
independent assay
N/A
IgA and IgG whole cell
antigens
III Saliva Chemiluminescence 
immunoassay
N/A
IgA and IgG whole cell
antigens
III Serum ELISA N/A
IL-1β I Saliva Luminex 0.4 pg/ml
IL-17A I Saliva Luminex 0.2 pg/ml
IL-23 I Saliva Luminex 28.6 pg/ml
LTA IV Saliva Luminex 0.3 pg/ml
IL-8 IV Saliva Luminex 0.2 pg/ml
MPO IV Saliva ELISA 0.2 ng/ml
RANKL II Saliva Luminex 4.8 pg/ml
OPG II Saliva Luminex 1.42 pg/ml
Osteocalcin II Saliva Luminex 39.2 pg/ml
Osteopontin II Saliva Luminex 67.8 pg/ml
Insulin II Saliva Luminex 46.3 pg/ml
Insulin II Serum Radioimmunoassay N/A
Glucose II Serum Hexokinase method N/A
HbA1c II Serum Immunoturbidimetric
method
N/A
CRS III and IV Saliva Combination marker:
Luminex + IFMA +
qPCR
N/A
ELISA = enzyme-linked immunosorbent assay, IFMA = time-resolvent immunofluorometric assay,
LAL = Limulus Amebocyte Lysate, LOD = limit of detection, N/A = not available, qPCR = quantitative 
real-time PCR
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4.3.1 Subgingival bacterial levels
In the Parogene study, pooled subgingival plaque samples were collected from the
deepest pocket of each jaw quadrant as described by Mäntylä et al. (2013). 
Checkerboard DNA-DNA hybridization was used to determine the levels of 29
bacterial species (30 strains). Detailed analyses were performed with the levels of A.
actinomycetemcomitans (strains Y4 plus ATCC 29523), P. gingivalis, P. 
endodontalis, P. intermedia, and T. forsythia (Socransky et al., 2004; Pradhan-
Palikhe et al., 2013). Details of 18 Gram-negative species (19 strains) and 11 Gram-
positive species, used in analyses, are presented in Table 2. 
Table 2. Summary of 18 Gram-negative species (19 strains) and 11 Gram-positive species.
SPECIES GRAM-POSITIVE GRAM-NEGATIVE
Detailed plus sum analyzed Aggregatibacter
actinomycetemcomitans
(strains Y4 plus ATCC 29523)
Porphyromonas endontalis*
Porphyromonas gingivalis
Prevotella intermedia
Tannerella forsythia
Only Sum analyzed Actinomyces israelii
Actinomyces naeslundii
Actinomyces neuii
Actinomyces odontolyticus
Parvimonas micra
Streptococcus constellatus
Streptococcus gordonii
Streptococcus intermedius
Streptococcus mitis
Streptococcus oralis
Streptococcus sanguinis
Campylobacter gracilis
Campylobacter rectus
Campylobacter showae
Capnocytophaga gingivalis
Capnocytophaga ochracea
Capnocytophaga sputigena
Eikenella corrodens
Fusobacterium nucleatum ssp.
naviforme
Fusobacterium nucleatum ssp. 
nucleatum
Fusobacterium nucleatum ssp.
polymorphum
Fusobacterium periodonticum
Veillonella parvula
Treponema denticola
*Porphyromonas endodontalis was used only in detailed analyses.
4.3.2 Lipopolysaccharide activity
Before measurements, saliva supernatants were diluted with endotoxin-free water. LPS
activity was determined from the serum samples (1:5, vol/vol) and the saliva supernatant
(1:40.000, vol/vol) by a commercially optimized Limulus Amebocyte Lysate (LAL)
assay coupled with chromogenic substrate (Hycult Biotec, Uden, Netherlands). 
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4.3.3 Phospholipid transfer protein detection and activity
Saliva PLTP was isolated from saliva samples of six apparently healthy volunteers
using heparin affinity column run with a high-pressure liquid chromatography 
(HPLC) technique. The fractions containing PLTP activity were pooled and applied
to a 12.5% SDS-PAGE and visualized by using the monoclonal anti-PLTP antibody,
Mab59 followed by a horseradish peroxidase labelled goat-anti-mouse antibody 
(Study IV). 
PLTP-facilitated phospholipid transfer activity was measured with a lipoprotein
independent assay. The methodology has been described and published earlier
(Jauhiainen and Enholm, 2005). 
4.3.4 Cytokines, bone remodeling-related biomarkers, and
insulin
Salivary concentrations of IL-1β, -8, -17A, -23, LTA, RANKL, OPG, osteocalcin,
osteopontin, and insulin were determined by the flow cytometry-based Luminex
technology (Luminex, Austin, TX) using the commercially optimized kits (EMD
Millipore, Billerica, MA) as recommended by the manufacturer. A detailed
description of the Luminex technology can be found elsewhere (Tighe et al., 2013). 
4.3.5 Myeloperoxidase
Salivary MPO concentrations were determined by commercially optimized ELISA
kits, as recommended by the manufacturer (Immunodiagnostik, Bensheim,
Germany).
4.3.6 Serum glucose, insulin, and glycated hemoglobin
Serum-based measurements on diabetes-related biomarkers (glucose, insulin, glycated 
hemoglobin A1c (HbA1c), and homeostatic model assessment-insulin (HOMA-IR))
were performed in collaboration with National Institute for Health and Welfare. After
a minimum of 4 hours fasting, serum glucose concentration was measured with an
automated clinical chemistry analyzer (AU400, Olympus, Tokyo, Japan). A 
radioimmunoassay kit (Phadeseph insulin RIA, Pharmacia, Uppsala, Sweden) was
used to measure serum insulin concentrations. An immunoturbidimetric method
(Abbot Laboratories, Abbot Park, IL) was used to measure serum HbA1c. The
HOMA-IR was used to determine insulin sensitivity by the following formula: (fasting
insulin x fasting glucose)/22.5 (Matthews et al., 1985).
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4.4 Statistical analyses
A commercial statistical program was used in all studies to analyze the data (SPSS
v. 21.0, IBM, Armonk, NY, USA). A part of the salivary markers measured with
Luminex did not reach the LOD in some of the samples and the values under
detection limit were substituted with LOD/2 (Whitcomb and Schisterman, 2008) (I, 
II), or value 0.01 pg/ml for LTA (IV), for statistical analyses. Furthermore, in Study
II, RANKL and osteocalcin results were not included in the analyses of associations,
since the number of samples under LOD was >30% (Uh et al., 2008).
Kolmogerov-Smirnov test and histograms (Chan, 2003a) were used to check the
normality of the data distributions. Because of the skewed nature of the data of
salivary biomarkers (Chan, 2003b), non-parametric tests (multiple comparisons with
Kruskal-Wallis H test and comparisons of differences between two independent
groups with Mann-Whitney U test) were used (I, II), or logistic regression models
were applied (III), or values were logarithmically transformed before tests to reach
normal distribution, and then parametric tests were used (III, IV).
In comparisons, p-values <0.05 (Study I, II, and III) or <0.01 (Study IV) were 
considered statistically significant.
4.4.1 Characteristics of the study population
The analysis of variance with post hoc pairwise comparisons (Tukey test) was used
for following variables: age, number of teeth, number of teeth with PPD ≥4 mm, and
BMI in comparisons with differences among the study groups (control, LP1, LP2,
and GP) (I, II). Pearson χ2 test (Chan, 2003b) was used to compare the percentages 
of men and smokers among these study groups. T-test was used to compare age,
number of teeth, and BMI among the periodontitis risk haplotype groups (IV). 
Joncheere-Tersptra test was used to compare age and number of teeth among the
CRS groups (CRS I–III) (III). Chi-square test (Chan, 2003c) was used to compare 
sex, smokers, diabetics, individuals with dyslipidemia and significant coronary
artery disease in angiography among the CRS groups or among the periodontitis risk
haplotype groups (III, IV).
4.4.2 Relationship of salivary biomarkers and different 
groups
Non-parametric comparisons between two independent groups were performed with
Mann-Whitney U test and multiple comparisons with Kruskal-Wallis H test (Chan,
2003b) (I, II). Parametric comparisons between two independent groups were
performed with t-tests and multiple comparisons with One-Way ANOVA
(independent salivary biomarkers) or Chi-square test (CRS) (Chan, 2003b; Chan,
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2003c) (IV). Jonckheere-Tersptra test was used when examining the relation of CRS
groups I–III to serum or saliva IgA/IgG, LPS activity, and subgingival bacterial
levels (III). Further analysis of the relationship between salivary biomarkers and 
ABL, age, and serum biomarkers was performed by converting continuous variables
to categorical variables (in tertiles) (II). Spearman correlation analysis (Chan,
2003d) was used to evaluate correlations between salivary, serum, and periodontal
parameters (I–II).
4.4.3 Analyses of association
Logistic regression analysis (Chan, 2005) was used to study associations of salivary 
IL-17A and IL-1β concentrations with different periodontal health state (I), salivary
osteoprotegerin as tertiles with GP (II), high CRS (III vs. CRS I–II) with serum or 
saliva IgA/IgG and LPS activity, and subgingival bacterial levels (III), and salivary
biomarkers, including CRS, with the genetic risk haplotype (IV). Linear regression
model (Chan, 2004) was used to study associations of salivary biomarkers, including
CRS, with seven different LTA SNPs (IV). See the detailed information of
adjustments of regression models in Studies I–IV. 
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5 Results and Discussion
5.1 General and methodological aspects
This PhD work consists of four individual studies. which concern the potential of
biomarkers in salivary diagnostics from a different point of view. Together, these
individual studies test the power and validity of infection, inflammation, and tissue
destruction-related biomarkers, starting with their individual use and ending up to 
their combinational use in detection of periodontitis. Although saliva is the main
specimen, serum components and genetic aspects are also included in this PhD
thesis. Host response was the main focus in Study I where results revealed the role 
of the IL-23/IL-17 axis at early stages of inflammation as well as reinforced the role
of IL-1β as a marker of advanced periodontitis. Study II continued with host
response, focusing on bone-related biomarkers, and enhanced the hypothesis that
glycemic status may influence biomarker concentrations in saliva. Studies III and 
IV included a combinatory salivary biomarker CRS besides the individual
biomarkers. According to Study III, CRS associates strongly with bacterial
biomarkers and salivary humoral response against them. In Study IV, it was 
demonstrated that CRS, as well as IL-8 and MPO, associates with periodontal
inflammation and tissue destruction. 
The relatively large sample sizes (n = 220 in the Health 2000 survey and n =
445/455 in the Parogene study) form one of the major strengths of this PhD work.
The age profile of these study populations (40–60 years) was suitable for the study
purposes, since the prevalence of periodontitis increases among middle-aged and 
older individuals. A wide range of information on oral, including panoramic
examination, and general health gave a good base to evaluate periodontal status of
the study participants. In studies using Health 2000 data (I and II), the effects of
systemic conditions were reduced by selecting non-diabetic individuals. In contrast, 
in studies using Parogene data (III and IV), the study population consists of 
individuals with symptomatic heart disease, and the results may not be fully
applicable to healthy individuals. 
Lack of a standardized time point of the day for saliva collections, sextant-based
measurements of gingival inflammation, and lack of information on clinical
attachment levels are among the limitations of this PhD work. In addition, a cross-
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Results and Discussion
sectional study design does not allow us to propose a cause-and-effect relationship
between tested markers and parameters nor either estimate the phase of the disease
activity of study individuals. On the other hand, large sample sizes and biomarkers
representing different phases of the disease process reduce the impact of individual
variation of biomarker levels at a certain time point. It is also notable that the genetic 
information is not bound to any time point. 
A methodologically interesting finding of this PhD work was presented in Study
I. The salivary concentrations of IL-1β were measured previously from the same 
samples with ELISA (Gürsoy et al., 2009). According to the results, IL-1β 
concentrations may stay rather constant when stored at -70°C, and besides ELISA, 
the Luminex technique proved to be suitable to measure this biomarker from saliva.
In the literature, there is quite a lot of variation in measuring techniques and LODs
between studies. This, combined with different definitions of periodontitis and 
inability to evaluate individual variations, makes comparisons between previous and
current results rather challenging. 
5.2 Biomarkers of infection
Lipopolysaccharide produced by Gram-negative periodontal pathogens is one of the
main inducers of host immune response in periodontal tissues. In this PhD work, 
LPS activity was measured from saliva (I, III) and serum (III) samples by the LAL 
assay, which is the most sensitive and most widely used method for detecting LPS 
activity (Manco et al., 2010). It measures biologic activity of a mixture of endotoxins
present in saliva or serum instead of evaluating the amount of LPS of specific
periodontal pathogens. In Study I, LPS did not differ significantly among the three
periodontitis (LP1, LP2, and GP) or control groups, and no correlation between LPS
activity and tested salivary interleukins (IL-1β, IL-17A, and IL-23) was found. In
the literature, there are two studies available on LPS activity in saliva regarding
periodontitis or periodontal parameters (Hyvärinen et al., 2012; Liljestrand et al., 
2017). According to these studies, salivary LPS activity correlated with the number
of teeth and amount of alveolar bone loss in linear trends. In Study I, all participants
had at least 20 teeth and alveolar bone loss was not included as a clinical parameter,
thus it was not possible to correlate salivary LPS activity with these parameters.
Therefore, in the absence of confirmatory data, LPS activity may not be considered
a suitable biomarker for salivary diagnostics, at least not as the sole parameter, since 
it seems to reflect rather overall microbial load and not changing directly with 
periodontal inflammation. 
According to our hypothesis, PLTP activity could be another potential
biomarker of Gram-negative bacterial load, since it has a protective role against
inflammation triggered by LPS. To the author’s best knowledge, Study IV is the
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first to demonstrate that PLTP can be isolated, identified in saliva and that PLTP 
activity can be measured from saliva samples. Limited data are available regarding
PLTP activity in relation to periodontitis. In one study, plasma PLTP activity levels 
were shown to decrease after periodontal treatment (Pussinen et al., 2004). In other
study, plasma PLTP activity was elevated in individuals with periodontitis
compared to the reference group (Vuletic et al., 2008). Additionally, plasma PLTP
activity inversely correlated with average PPD per tooth, but median PLTP activity
did not change significantly after full-mouth tooth extraction. In Study IV, 
measured levels of PLTP activity in saliva were approximately 1/10 compared to
those measured from plasma samples (Pussinen et al., 2004), and PLTP activity
did not relate to the periodontal parameters (BOP, PPD, and ABL) or to the number
of teeth. Lack of relation to periodontal parameters and relatively low salivary
concentrations of PLTP activity indicate that it does not tend to be a potential 
salivary biomarker.  
5.3 Biomarkers of inflammation
Interleukin-1β is a well-established salivary biomarker of periodontal
inflammation, but also associated with tissue destruction and osteoclast activation.
IL-1β was included in the pattern of examined cytokines, because of it’s essential
role in the inflammation cascade. With this, the aim was to use IL-1β as a reliable
reference marker in evaluation of levels of previously untested salivary cytokines,
i.e., IL-17A and IL-23. According to the results of Study I, salivary concentrations
of IL-1β were significantly elevated in the GP group compared to other groups
(control, LP1, and LP2) (p <0.001). In further analyses (logistic regression
models), there was a significant association between the GP group and IL-1β
concentrations when age, sex, and smoking were included as confounding 
variables and the control group was taken as a reference (p = 0.002). The results 
of this PhD work reinforce the view that elevated salivary levels of IL-1β indicate
advanced periodontitis rather than being a marker of initial stage of periodontitis. 
This observation is in line with previous results referred in Table 3. Repetitive and
systematic changes of IL-1β salivary concentrations among periodontitis groups
support its use as a single or combinatory salivary biomarker of periodontitis
(Gürsoy et al., 2011; Jaedicke et al., 2016).
Interleukin-8 is an acute phase chemotactic cytokine. In this PhD work, elevated
concentrations of IL-8 were observed with increased BOP values (0–25%, 26–50%, 
and 51–100%) and deepened pockets (PPD <4 mm, 4-5 mm, and ≥6 mm) groups
(p = 0.006 and p = 0.001). In contrast, there was no difference between different 
ABL groups (no, 1/3, and ≥2/3). Furthermore, elevated salivary concentrations of
IL-8 were detected with the increased number of teeth (1–10, 11–20, and 21–32)
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Results and Discussion
(p < 0.001) (Figure 8). These findings confirm the role of IL-8 as an acute phase
biomarker. The suitability of IL-8 for salivary diagnostics of periodontitis remains
unclear, since few periodontal parameters were used in Study II and moreover, there 
are conflicting findings in the literature (Table 3). Also, a recent meta-analysis 
reported conflicting findings regarding IL-8 saliva concentrations, while
concentrations in GCF were significantly lower (Finoti et al., 2017). Plausible
reasons behind these inconclusive results are methodological or related to the 
presence of putative inhibitors of IL-8 in saliva (e.g., mucin-like proteins or other
large molecules and enzymes).
The hypothesis of Study I was that the severity of periodontitis relates to ILs, 
including IL-17A and IL-23 levels in saliva. IL-23 is linked to IL-17 via its ability 
to promote the differentiation of naive CD4+ T-cells into Th17, cells which 
produce IL-17 family cytokines. Of those, IL-17A was selected to be examined in
this PhD work. Various effects of it are the result of synergy with other cytokines 
like IL-1β, TNF-α, and INF-γ (Kramer and Gaffen, 2007; Korn et al., 2009; Onishi
and Gaffen, 2010; Cheng et al., 2014). Only few studies have reported the levels
of salivary IL-17A in relation to periodontitis, while studies on salivary levels of
IL-23 in periodontitis are lacking. Previous reports indicate conflicting findings
both for IL-17A and for IL-17 without further subgrouping (Table 3). Gürsoy and 
coworkers (2015) presented an association between mean depth of periodontal
pockets and salivary IL-17A concentrations. The findings of Study I suggest that 
salivary levels of IL-17A and IL-23 are connected to localized periodontitis (LP1 
or LP2). There was also a slight difference in salivary levels of IL-17A and IL-23 
between the control and GP groups. The p-values are presented in Figure 6. In 
further analyses of association, a significant association was found between LP1,
LP2, and GP groups and elevated IL-17A concentrations in saliva when age, sex, 
and smoking were included in the model as confounding variables and the control
group was taken as reference (p <0.001, p <0.001, and p = 0.009). However, there 
were no significant associations between periodontal groups and salivary IL-23. 
Concentrations of IL-17A and IL-23 correlated weakly but significantly (Spearman
ˆ: 0.134; p = 0.048). 
On the basis of these findings, it can be speculated that the IL-23/IL-17 axis
reinforces proinflammatory immune responses at early stages of inflammation. In an 
immunohistochemical study on gingival biopsies, in which mild, moderate, and
severe periodontitis groups were included, an increase in tissue IL-17 levels with the
progression of periodontitis was demonstrated (Lester et al., 2007). In contrast, 
distinct elevation and reduction profiles of IL-17 were not observed, like were done
in Study I. To the best of authors’ knowledge, this study was the first to investigate
salivary concentrations of IL-17A and IL-23 in a large study population, where also
individuals with localized periodontitis were represented. The results indicate that 
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elevated levels of IL-17A and IL-23 are limited to the early stages of periodontitis.
However, during the analyses, a significant percentage of detected cytokine
concentrations remained under LOD: 20% for IL-17A (LOD 0.2 pg/ml) and 61.8%
for IL-23 (LOD 28.6 pg/ml). As this phenomenon may affect the results, their
usability in salivary diagnostics is restricted. Low salivary concentrations of IL-17 
have been demonstrated previously as well (values under LOD 91.3% (LOD 4.2 
pg/ml)) (Isaza-Guzmán et al., 2015). Despite the similar profile of these two markers,
IL-17A is a more promising candidate for salivary diagnostics than IL-23, since
salivary concentrations of IL-17A were higher than those of IL-23. Further research 
is needed to develop more sensitive laboratory techniques for their detection in saliva 
samples. This could improve the usability of these two biomarkers in salivary
diagnostics of periodontology.  
Lymphotoxin-˜ was studied in Study IV to examine its association with the
carriage of gene polymorphisms (discussed in section 5.6). LTA is able to induce
neutrophils to secrete MPO (Richter, 1990). The literature on LTA is limited and the
few available studies present conflicting results in terms of the relation between 
salivary LTA concentrations and periodontal status (Table 3). In this PhD work, 
salivary LTA concentrations did not relate to BOP, PPD, ABL, or the number of
teeth. Furthermore, its levels were relatively low, only 1/100 compared to those
measured from serum samples (Kallio et al., 2014), leading to a large percentage of
values under LOD (48.4%). Low LTA levels are likely to affect the reliability of the
current findings. In future, the development of more sensitive laboratory methods
may improve the usability of LTA as a salivary marker in periodontology. However,
at present its suitability in salivary diagnostics remains unclear. 
Myeloperoxidase is an interesting salivary biomarker, since it has a dual role in
the periodontal disease process; on the one side it functions to kill bacteria and on
the other side it activates latent proMMPs (Saari et al., 1990; Spallarossa et al., 2008;
Hernández et al., 2011). Previous findings, as referred in Table 3, suggest that
elevated salivary levels of MPO relate to the severity of periodontitis especially via
its role in tissue destruction. According to the results of this PhD work, salivary MPO 
concentrations differed significantly among different groups of BOP (0–25%, 26– 
50%, and 51–100%), PPD (<4 mm, 4–5 mm, and ≥6 mm) and ABL (no, 1/3, and
≥2/3) values (p < 0.001 for all groups) (Figure 8). These findings indicate that MPO
is a marker of periodontal inflammation and are in line with the literature. It seems
that MPO is a potential biomarker for salivary diagnostics in periodontology. The
results regarding an association of MPO concentrations in saliva with periodontal
risk haplotype are discussed later in this section. 
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Table 3. Summary of findings in the literature on the presence of the tested inflammatory
biomarkers in saliva.
CHANGE IN PERIODONTITIS
REF SPECIMEN IL-1Β IL-8 IL-17A IL-23 LTA MPO NOTE!
Miller et al., 2006 Saliva ˇ
Ng et al., 2007 Saliva ˇ
Tobón-Arroyave et
al., 2008
Saliva ˇ
Gürsoy et al.,
2009
Saliva ˇ
Fine et al., 2009 Saliva ˇ
Salminen et al.,
2014
Saliva ˇ
Scannapieco et
al., 2007
Saliva ˘
Teles et al., 2009 Saliva ˘
Rathnyake et al.,
2013
Saliva ˘
Kim et al., 2016 Saliva ˇ
Özcan et al., 2016 Saliva ˇ
Kaczyński et al.,
2019
Saliva ˇ ˇ
Ozçaka
et al., 2011a
Saliva 
Awang et al., 2014 Saliva ˇ
Prakasam and 
Srinivasan, 2014
Saliva  No IL-17 
subgrouping
Gürsoy et al.,
2015
Saliva ˇ Probing pocket
depths were taken 
as independent
variable 
Isaza-Guzmán et
al., 2015
Saliva ˘ No IL-17 
subgrouping and 
only 8.7% over
LOD
Marques et al.,
2016
Saliva ˇ No IL-17 
subgrouping
Yang et al., 2016 Saliva ˇ No IL-17 
subgrouping
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CHANGE IN PERIODONTITIS
REF SPECIMEN IL-1Β IL-8 IL-17A IL-23 LTA MPO NOTE!
Batool et al., 2018 Saliva ˇ No IL-17 
subgrouping
Himani et al.,
2014
GCF ˇ Periodontal tissue
damage was taken
as independent
variable
Sadeghi et al., 2018 GCF ˘
Kallio et al., 2014 Serum ˇ Deepened 
periodontal pockets 
of 4-5 mm and the 
number of teeth 
were taken as 
independent
variables
Shyu et al., 2015 Saliva  Inverse relation 
with the percentage 
of periodontal
pockets and LTA
Sakamoto et al., 2008 Saliva ˇ
Meschiari et al.,
2013
Saliva ˇ
Nizam et al., 2014 Saliva ˇ
Rathnayake et al.,
2015
Saliva ˇ
Lahdentausta et
al., 2018
Saliva ˇ
ˇ = higher concentration;  = lower concentration; ˘ = no change on concentration; GCF = gingival
crevicular fluid; LOD = limit of detection
5.4 Biomarkers of bone metabolism
Remodeling of alveolar bone stimulates the release of several bone metabolism-
related biomarkers, which eventually end up to saliva. In Study II, the
concentrations of salivary biomarkers RANKL, OPG, osteocalcin, osteopontin, and 
insulin were measured. In addition, serum concentrations of insulin, glucose, and 
HbA1c were measured and HOMA-IR was defined based on insulin and fasting 
glucose values. According to the hypothesis, insulin and glycemic status may affect
the salivary concentrations of bone remodeling-related biomarkers. Glycemic status 
was presented as a confounding factor on the interactions between periodontal status
and bone remodeling-related biomarkers. It was found that salivary concentrations 
of RANKL, osteocalcin or osteopontin were not related to periodontal status. 
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Results and Discussion
Concerning RANKL and osteocalcin, in a remarkable proportion of saliva
samples, the detected concentrations remained under LOD or were very low (47.7%
and 43.2%, respectively). The low concentration or no detection of RANKL in saliva
is in line with an observation by Frodge et al. (2008). Higher levels of osteopontin
were found in the middle ABL tertile (3-13 mm of ABL) compared to the highest ABL
tertile (> 13 mm of ABL) (p <0.05). Of the tested bone-related markers, OPG was the
most promising candidate for salivary diagnostics: only one sample was under LOD
and elevated salivary concentrations of OPG were found in LP2 and GP groups
compared to controls (p <0.05, see Figure 6). In further analyses (logistic regression
analysis), elevated OPG concentrations in saliva associated with GP when the age, sex, 
smoking, and glycemic status were included in the model as confounding variables
and the control group was taken as reference (p = 0.03), but statistically significant
association was lost when salivary insulin was included in the model. 
The literature regarding salivary concentrations of these bone biomarkers is limited 
(Table 4). Before this PhD work, the only available data on osteopontin levels in oral
fluids was limited with studies using GCF as a sample material. Based on these studies,
elevated osteopontin concentrations have been found in periodontal pockets of
periodontitis individuals in comparison to periodontally healthy sites. The results of our
study showed higher salivary osteopontin concentrations in middle ABL tertile (3-13 
mm of ABL). As seen in Table 4, there are conflicting OPG findings in saliva in relation
to periodontitis. The present results are in line with those demonstrating elevated
salivary OPG concentrations in periodontitis individuals (Miller et al., 2006; Costa et
al., 2010; Al-Sabbagh et al., 2012). It is notable, that all tested salivary biomarkers
except insulin, differed significantly between genders; the concentrations of RANKL, 
osteocalcin, and osteopontin were higher and that of OPG was lower in females than in
males (p < 0.05). Mechanisms behind these observations remain to be clarified. 
None of the tested bone biomarkers works as an ideal salivary biomarker to
detect periodontitis. The present work did not consider the RANKL/OPG ratio,
which might be more suitable for salivary diagnostics than either one alone (Table
4). However, extremely low RANKL levels in saliva remain undetectable in the
majority of the cases, limiting the usability of the RANKL/OPG ratio as a salivary
biomarker of periodontitis. It may not be feasible to compare the power and validity
of biomarkers in different body fluids, since each body fluid carries its own 
physiological characteristics. Differences in pH, temperature, volume, viscosity, and
enzymatic activity are significant determinants in detecting of proteins (Proctor,
2016), in particular, if present at low levels.
In the literature, the controversial results on bone remodeling-related salivary
biomarkers are often explained by factors unrelated to bone turnover, such as the
clearance and half-life of the indicated biomarker or methodological aspects, but not by 
glycemic status. Santos and coworkers (2010), using GCF samples, demonstrated that
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poor glycemic control in type II diabetic individuals may influence negatively RANKL
concentrations and RANKL/OPG ratios before and after periodontal treatment. To the
best of the authors’ knowledge, Study II was the first to evaluate effects of the glycemic
status and insulin profile on salivary bone remodeling-related biomarkers. Salivary
insulin significantly affected the observed association between OPG and periodontal
status. In serum-based studies, OPG concentrations have been shown to increase with
the presence of diabetes (Browner et al., 2001) and correlate positively with fasting
glucose levels (Shin et al., 2006). Insulin can regulate OPG expression of osteoblasts
through insulin receptors, and increased concentrations of insulin inhibit the OPG
expression, leading changes in the RANKL/OPG ratio (Ferron et al., 2010). In line with 
this background, results of this PhD work showed negative correlation between salivary
insulin and OPG (Spearman ˆ: -0.15; p < 0.05). To demonstrate a causal relationship 
between salivary OPG and insulin levels, a longitudinal study design is warranted. 
Besides the pancreas, salivary glands are a potential source of salivary insulin
(Kerr et al., 1995). As shown in Study II, insulin concentrations in saliva and serum
correlated with each other (Spearman ˆ: 0.34; p < 0.001), indicating that salivary
insulin levels are mainly affected by serum insulin levels. Salivary glands can also
secrete osteopontin (Obermüller et al., 2006). Osteopontin is involved in the
pathogenesis of insulin resistance and type I diabetes (Kahles et al., 2014), and serum
insulin and osteopontin levels correlate in obese subjects (Riedl et al., 2008). 
According to the results of this PhD work, concentrations of salivary insulin and 
salivary osteopontin correlate significantly (Spearman ˆ: 0.74; p < 0.001). 
Furthermore, there was a correlation between insulin resistance values (HOMA-IR) 
and salivary osteopontin (Spearman ˆ: 0.17; p < 0.05). These findings indicate that
glycemic status significantly affects osteopontin levels in saliva. It has been shown 
that active osteocalcin promotes the proliferation and insulin secretion of pancreatic
beta cells, which eventually leads to the insulin sensitivity (Ferron et al., 2010;
Karsenty and Ferron, 2012). In addition, insulin has a direct effect on bone 
metabolism and circulating biomarkers related to bone metabolism (Ivaska et al.,
2015). However, because of low salivary concentrations of osteocalcin and RANKL, 
it remained unclear whether glycemic status has an effect on these bone markers.
Several pathways are affected by diabetes and insulin, and this PhD work does
not describe a cause-and-effect relationship between the tested markers and
parameters. It has been shown that advanced glycation end-products and their
receptors increase RANKL and decrease OPG synthesis in different cell lines
(Taylor et al., 2013). At the same time, they activate the osteoclast formation and
activation. Furthermore, in hyperglycemia proinflammatory cytokines IL-1β and IL-
6 are increased in periodontal tissues, leading to stimulation of alveolar bone
resorption (Taylor et al., 2013). 
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Table 4. Summary of previous literature of bone remodeling-related biomarkers.
CHANGE IN PERIODONTITIS
REF SPECIMEN RANKL OPG RANK/
OPG 
RATIO
OSTEO-
CALCIN
OSTEO-
PONTIN
NOTE!
Frodge et al.,
2008
Tobón-
Arroyave et
al., 2012
Tabari et al.,
2013
Ochanji et
al., 2017
Borges et al.,
2019
Miller et al.,
2006
Ramseier et
al., 2009
Costa et al.,
2010
Al-Sabbagh
et al., 2012
Bullon et al.,
2005
Ozçaka et
al., 2011b
Miricescu et 
al., 2014
Betsy et al., 
2019
Kido et al., 
2001
Sharma and 
Pradeep,
2006
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
Saliva
GCF
GCF
˜
°
°
°
°
˛
˜
˛
°
˛
°
°
°
°
°
˜
°
°
°
°
°
Only 19% over LOD
A strong positive 
correlation of the
RANKL/OPG ratio to
disease severity
A relatively small n
GCF osteocalcin
concentrations were 
significantly higher in 
periodontitis group
° = higher concentration/ratio; ˛ = lower concentration/ratio; ˜ = no change on concentration/ratio;
GCF = gingival crevicular fluid; LOD = limit of detection
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Figure 6. Summary of statistically significant relations of salivary biomarkers and periodontal
status (health, localized (LP1 and LP2), and generalized periodontitis (GP)). 
5.5 Subgingival bacteria, immunoglobulins and 
periodontal parameters in association with
Cumulative Risk Score
In salivary diagnostics, it is crucial to understand the interactions between the host
and microbes. The diversity of the oral microbiome makes it rather impossible to
evaluate this interaction in all directions (Wade, 2011). Highly specialized members
of biofilm communities can dysregulate the host immune response and cause
dysbiosis (Sanz et al., 2017). The presence of multiple periodontopathic species in
saliva associate strongly with periodontitis (Paju et al., 2009), as does salivary IL-1β 
too (Gürsoy et al., 2009). 
CRS, a combinatory salivary biomarker, represents the aspects of bacterial
burden, host response, and their effects on surrounding tissues. In Study III, the 
ability of CRS to describe the changes in the salivary and subgingival
microbiological profile in periodontitis was studied. The levels of all examined
subgingival bacteria and bacterial clusters were significantly elevated in individuals
with high risk of having periodontitis (CRS group III) (p < 0.001). The association
with subgingival P. gingivalis was expected, but its association with other
periodontitis-related bacteria was a novel finding. In further association analyses
(logistic regression model), the model being adjusted for age, sex, number of teeth,
and subgingival bacterial levels, the sum of subgingival Gram-negative species
associated with high CRS (odds ratio (OR) 6.191, 95% confidence interval (CI)
2.098–18.27, p = 0.001). These findings indicate that CRS, a combinatory salivary
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Results and Discussion
biomarker, is able to reflect microbial shifts due to periodontitis at subgingival sites.
A recent saliva-based study found positive correlations between Treponema and 
Selenomas and the tested cytokines (chitinase 3-like 1, sIL-6Rα, sTNF-R1, and
gp130/sIL-6Rβ) and a negative correlation between IL-10 and Filifactor alocis
(Lundmark et al., 2019), confirming the interaction between periodontal pathogens
with inflammatory mediators seen in saliva. 
Salivary LPS activity is not considered a candidate biomarker for recognizing 
individuals with periodontitis. The grouping of controls and periodontitis individuals
(LP1, LP2, and GP) in this PhD work may have an influence on the present results.
However, Study III showed that LPS activity in saliva associates with high CRS
(OR 2.191 (95% CI 1.384-3.468, p = 0.001)) when logistic regression model adjusted
for age, sex, number of teeth, and subgingival level of the bacterial species was used. 
The finding is new and fits with the hypothesis that CRS enhances the possibility to
recognize altered bacterial burden related to periodontitis.
In addition to the salivary levels of LPS activity, serum levels were determined
in Study III. According to Liljestrand et al. (2017), there is a correlation between
saliva and serum LPS activity levels, and a significant part of circulating LPS may
originate from the oral cavity. In an animal study with mice (Sato et al. 2017), the
oral administration of P. gingivalis changed the gut microbiome and elevated serum
endotoxin levels. Although it has been shown that serum LPS correlates with
periodontal status and serum LPS activity is decreased after periodontal treatment
(Pussinen et al., 2004; Paju et al., 2006; Masi et al., 2018), Study III did not find 
any association between serum LPS activity and high CRS. This indicates that
combining the information on serum LPS activity to CRS does not improve the
diagnostic ability of CRS. 
In Study III, high CRS associated significantly with salivary IgA/IgG antibody
levels of A. actinomycetemcomitans, P. gingivalis, P. endodontalis, P. intermedia, 
and T. forsythia (p < 0.001). Furthermore, the sum of IgA/IgG antibody levels against
A. actinomycetemcomitans, P. gingivalis, P. endodontalis, P. intermedia, and T.
forsythia associated with high CRS (for IgA, OR of 7.043, 95% CI 2.252-22.02, p =
0.001 and for IgG, OR of 3.788, 95% CI 1.777-8.077, p = 0.001), when logistic
regression model was used and model was adjusted for age, sex, number of teeth, 
and subgingival level of the bacterial species. In serum-based analyses, high CRS
associated significantly only with the IgA antibody levels of A.
actinomycetemcomitans (p = 0.007), P. endodontalis (p < 0.001), and P. intermedia
(p = 0.021) and with the IgG antibody levels of P. gingivalis (p = 0.040) and P.
endodontalis (p < 0.001). Serum antibody levels were independent from subgingival
bacterial levels. It seems that CRS associates more strongly with the local response.
This is in line with an observation that serum IgA/IgG levels of P. gingivalis and A.
actinomycetemcomitans mostly relate to periodontal pathogen carriage, and
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periodontitis has at most a modest modifying effect to their levels (Pussinen et al., 
2011). In comparison to serum, saliva seems to be a more suitable specimen type to
recognize biomarkers of active periodontal inflammation. High CRS reflects well 
IgA/IgG antibody levels against periodontopathic species in saliva supporting the
suitability of CRS for salivary diagnostics of periodontitis. 
As shown in Study IV, higher CRS values associate with determined clinical 
parameters, including increased BOP, PPD, and ABL values, and the number of teeth 
(p < 0.001). This finding supports the suitability of CRS for large-scale studies for
detecting periodontitis and the idea that a combination of biomarkers would work
better than any single biomarker alone (Gürsoy et al., 2011; 2018; Salminen et al., 
2014). 
Figure 7. Summary of main findings related to CRS.
5.6 Periodontitis risk haplotype in association with 
biomarkers
Genomic approaches will allow researchers to characterize behavior of different
salivary biomarkers in individuals with different genetic backgrounds (Zeidán-
Chuliá et al., 2016). The genes of several inflammation-related proteins, e.g., heat
shock proteins, TNF, and lymphotoxins, are carried in telomeric end of human major
histocompatibility complex (MHC) class III region (Yung Yu et al., 2000). 
The hypothesis of Study IV was that PLTP activity, LTA, IL-8, MPO, and CRS
appear in saliva at different levels depending on the risk haplotype of MHC class III 
region BAT1-NFKBIL1-LTA and gene polymorphisms of LTA. In dominant or
recessive models of periodontal risk haplotype comparisons, none of the studied 
biomarkers or CRS differed significantly between the groups. In analysis of
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Results and Discussion
association, where the dominant risk haplotype was selected as an independent
variable and model was adjusted with age (Model 1), and additionally with gender, 
diabetes, and smoking (Model 2), and further with PPD (Model 3) or BOP (Model
4) or ABL (Model 5), MPO associated with increased odds of having periodontitis
risk haplotype (OR 1.372 (p = 0.007) in Model 3) per increase of logarithmically
transformed unit. Also, salivary PLTP activity, IL-8, and CRS associated slightly in 
all models with increased odds of having the periodontitis risk haplotype, but these
markers did not reach statistical significance. In analysis of association related to
LTA SNPs, LTA concentrations associated significantly with LTA gene variants 
rs2857708 (p = 0.011), rs2009658 (p = 0.006), and rs2844482 (p = 0.006).
Kallio and coworkers showed that the MHC class III region BAT1-NFKBIL1-
LTA risk haplotype (AGCGAC) is a significant contributor to increased risk of
periodontitis with the strongest association with BOP, PPD ≥6 mm, and severe 
periodontitis (Kallio et al., 2014). They also demonstrated that high serum
concentrations of LTA relate to periodontal risk alleles of the LTA gene. Moreover,
it has been shown that the LTA +496C variant associates significantly with alveolar
bone loss (Palikhe et al., 2008).
The novel findings of Study IV were that MPO concentration associated with
increased odds for having the risk haplotype and association of LTA with LTA gene 
variants. The polymorphisms of the LTA gene seem to have an impact on LTA
concentration in saliva, however, the high percentage of values under LOD restricts
the liability of current results. LTA can induce the secretion of MPO (Richter, 1990),
and it can be speculated that this may be the link between MPO and the risk
haplotype. The Parogene study population is rather small to investigate genetic 
associations and the power calculation was not applicable because some of the
salivary biomarkers used were new. Additionally, the study population consists of 
patients with symptomatic heart disease and thus results may not be fully applicable
to a general population, since MHC class III region BAT1-NFKBIL1-LTA may also
have a relation to heart diseases (Kallio et al., 2014). Larger general population-
based studies are warranted to confirm present novel findings.
Generally, the results of Study IV indicate that lymphocytic/systemic salivary
biomarkers (PLTP activity and LTA) relate to genetic factors, while local salivary
biomarkers (IL-8, MPO, and CRS) seem to have a stronger association with local
inflammation and tissue destruction. 
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Figure 8. Summary of statistically significant relations of salivary biomarkers and periodontal
parameters. Figure also summarizes associations of periodontitis risk haplotype.
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6 Conclusions
6.1 Conclusions
The main findings of this PhD thesis can be summarized as follows:
– PLTP activity was detectable in saliva and was the lowest in individuals
with advanced tooth loss. Salivary levels of PLTP activity were ten times
less than those previously measured from plasma samples. Therefore,
PLTP probably plays its main role elsewhere than in the oral cavity, and
may not considered a potential salivary biomarker. 
– LPS activity in saliva did not relate to periodontal status despite of its
association of high CRS. Therefore, its usability as a single biomarker is 
weak.
– IL-1° was associated with generalized periodontitis, in line with its well-
established salivary biomarker of periodontitis. IL-17 has the potential of 
a salivary biomarker, but its usability warrants further studies. Since IL-
23 levels remained under LOD in the majority of the samples, it cannot
be considered as a potential salivary biomarker.
– IL-8 concentrations were associated with BOP, PPD, and the number of
teeth, and additionally MPO concentration with alveolar bone loss,
indicating its potential as a biomarker of periodontal inflammation and
tissue destruction. 
– Salivary concentrations of bone remodeling-related biomarkers (RANKL,
OPG, osteopontin, osteocalcin) are either detected at very low levels or
affected by glycemic status. Therefore, their usability as salivary
biomarkers of periodontitis is weak. 
– CRS is a promising combinatory salivary biomarker for detecting
periodontitis in large-scale studies, since it associates strongly with the 
immunological and microbial profile of the disease.
– LTA concentration in saliva is associated with LTA gene variants, but not
with clinical or radiological parameters nor the examined risk haplotype.
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– MPO was the only biomarker associating with the MHC class III region
BAT1-NFKBIL1-LTA risk haplotype of periodontitis. Underlying
mechanisms between MPO and the risk haplotype remain unclear.
Figure 9. Summary of conclusions of this PhD thesis.
6.2 Future aspects
There is still a limited amount of data on how different conditions and risk factors
affect the levels of potential salivary biomarkers, including well-established
markers. It has been shown that smoking affects salivary levels of IL-8, MMP-8, 
MMP-9, TIMP-1, and MPO (Sorsa et al., 2016; Kanmaz et al., 2019; Lahdentausta
et al., 2019), and that IL-1β and IL-6 are not affected by smoking (Jaedicke et al.,
2016). Although systemic low-grade inflammation is associated with obesity, a 
recent study by Syrjäläinen et al. (2019) failed to find an association with obesity
and IL-1-receptor antagonist, IL-6, IL-8, IL-10, or TNF-˜. A review by Jaedicke et
al. (2016) stated caution to the conclusions on the impact of systemic diseases on
salivary cytokine levels; the amount of data is very limited and none of the reviewed
studies was designed specifically to investigate the effect of systemic diseases.
There is an increasing interest in moving towards personalized medicine in
periodontology and other fields of dentistry (Belibasakis et al., 2019). Improving the
understanding of the complexity of periodontal pathogenesis in relation to several
systemic conditions allows determining patient-specific diagnostics. It is expected
that in the future salivary diagnostics will have an important role in personalized 
medicine in periodontics (Ebersole et al., 2015; Korte and Kinney, 2016; Nagarajan 
et al., 2015; 2017)
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Conclusions
This PhD thesis provided evidence on the use of specific biomarkers in saliva 
for detecting periodontal disease in large-scale studies. Since saliva is an easily
collected specimen, it would also be tempting to be used in non-specialized clinical
settings. An inexpensive, portable, rapid, and reliable POC salivary diagnostic
equipment would launch salivary diagnostics of periodontology in the daily practice 
(Miller et al., 2010; He et al., 2018; Mitsakakis et al., 2019).
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